ACM Research, Inc. - Quarter Report: 2019 June (Form 10-Q)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
10-Q
(Mark One)
☑
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For
the quarterly period ended June 30, 2019
or
☐
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For
the transition period from _________ to _____________
frCommission file number: 001-38273
ACM Research, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
|
94-3290283
|
(State or Other Jurisdiction of Incorporation or
Organization)
|
(I.R.S. Employer Identification No.)
|
42307 Osgood Road, Suite I
Fremont, California
|
94539
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code:
(510) 445-3700
Securities
registered pursuant to Section 12(b) of the Act:
Title of Each Class
|
Trading Symbol(s)
|
Name of Each Exchange on which Registered
|
Class A
Common Stock, $0.0001 par value per share
|
ACMR
|
Nasdaq
Global Market
|
Indicate
by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such
shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for
the past 90 days. Yes ☑ No ☐
Indicate
by check mark whether the registrant has submitted electronically
every Interactive Data file required to be submitted pursuant to
Rule 405 of Regulation S-T during the preceding 12 months (or for
such shorter period that the registrant was required to submit such
files). Yes ☑ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See definitions of
“large accelerated filer,” “accelerated
filer,” “smaller reporting company” and
“emerging growth company” in Rule 12b-2 of the Exchange
Act.
Large
accelerated filer
|
☐
|
Accelerated
filer
|
☐
|
Non-accelerated
filer
|
☐
|
Smaller
reporting company
|
☑
|
Emerging
growth company
|
☑
|
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section13(a) of the Exchange Act. ☑
Indicate
by check mark whether the registrant is a shell company (as defined
in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑
Indicate
the number of shares outstanding of each of the registrant’s
classes of common stock, as of the latest practicable
date.
Class
|
|
Number of Shares Outstanding
|
Class A
Common Stock, $0.0001 par value
|
|
14,259,479
shares outstanding as of August 5, 2019
|
Class B
Common Stock, $0.0001 par value
|
|
1,883,423
shares outstanding as of August 5, 2019
|
TABLE OF CONTENTS
PART
I. FINANCIAL
INFORMATION
|
3
|
|
3
|
||
3
|
||
4
|
||
5
|
||
7
|
||
8
|
||
20
|
||
34
|
||
34
|
||
PART
II. OTHER
INFORMATION
|
35
|
|
35
|
||
38
|
||
38
|
||
39
|
We
conduct our business operations principally through ACM Research
(Shanghai), Inc., or ACM Shanghai, a subsidiary of ACM Research,
Inc., or ACM Research. Unless the context requires otherwise,
references in this report to “our company,”
“our,” “us,” “we” and similar
terms refer to ACM Research, Inc. (including its predecessor prior
to its redomestication from California to Delaware in November
2016) and its subsidiaries (including ACM Shanghai),
collectively.
For
purposes of this report, certain amounts in Renminbi, or RMB, have
been translated into U.S. dollars solely for the convenience of the
reader. The translations have been made based on the conversion
rates published by the State Administration of Foreign Exchange of
the People’s Republic of China.
SAPS,
TEBO and ULTRA C are our trademarks. For convenience, these
trademarks appear in this report without ™ symbols, but that
practice does not mean that we will not assert, to the fullest
extent under applicable law, our rights to the trademarks. This
report also contains other companies’ trademarks, registered
marks and trade names, which are the property of those
companies.
NOTE ABOUT FORWARD-LOOKING STATEMENTS
This
report contains forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. All
statements, other than statements of historical facts, included in
this report regarding our strategy, future operations, future
financial position, future revenue, projected costs, prospects,
plans and objectives of management are forward-looking statements.
In some cases, you can identify forward-looking statements by terms
such as “may,” “might,” “will,”
“objective,” “intend,”
“should,” “could,” “can,”
“would,” “expect,” “believe,”
“anticipate,” “project,”
“target,” “design,” “estimate,”
“predict,” “potential,” “plan”
or the negative of these terms, and similar expressions intended to
identify forward-looking statements. These statements reflect our
current views with respect to future events and are based on our
management’s belief and assumptions and on information
currently available to our management. Although we believe that the
expectations reflected in these forward-looking statements are
reasonable, these statements relate to future events or our future
operational or financial performance, and involve known and unknown
risks, uncertainties and other factors, including those described
or incorporated by reference in “Item 1A. Risk Factors”
of Part II of this report, that may cause our actual results,
performance or achievements to be materially different from any
future results, performance or achievements expressed or implied by
these forward-looking statements.
Any
forward-looking statement made by us in this report speaks only as
of the date on which it is made. Except as required by law, we
assume no obligation to update these statements publicly or to
update the reasons actual results could differ materially from
those anticipated in these statements, even if new information
becomes available in the future.
You
should read this report, and the documents that we reference in
this report and have filed as exhibits to this report, completely
and with the understanding that our actual future results may be
materially different from what we expect. We qualify all of our
forward-looking statements by these cautionary
statements.
2
PART
I. FINANCIAL INFORMATION
Item 1. Financial Statements
ACM RESEARCH, INC.
Condensed Consolidated Balance Sheets
(In thousands, except share and per share data)
(Unaudited)
|
June
30,
2019
|
December 31,
2018
|
Assets
|
|
|
Current
assets:
|
|
|
Cash
and cash equivalents
|
$27,578
|
$27,124
|
Accounts
receivable, less allowance for doubtful accounts of $0 as of June
30, 2019 and $0 as of December 31, 2018 (note 3)
|
31,393
|
24,608
|
Other
receivables
|
2,388
|
3,547
|
Inventories
(note 4)
|
45,494
|
38,764
|
Prepaid
expenses
|
1,547
|
1,985
|
Total
current assets
|
108,400
|
96,028
|
Property,
plant and equipment, net (note 5)
|
3,376
|
3,708
|
Operating
lease right-of-use assets, net (note 8)
|
4,550
|
-
|
Intangible
assets, net
|
307
|
274
|
Deferred
tax assets (note 15)
|
1,635
|
1,637
|
Long-term
investments (note 10)
|
1,738
|
1,360
|
Other
long-term assets
|
263
|
40
|
Total
assets
|
120,269
|
103,047
|
Liabilities and Stockholders’ Equity
|
|
|
Current
liabilities:
|
|
|
Short-term
borrowings (note 6)
|
15,110
|
9,447
|
Accounts
payable
|
18,238
|
16,673
|
Advances
from customers
|
5,684
|
8,417
|
Income
taxes payable
|
1,016
|
1,193
|
Other
payables and accrued expenses (note 7)
|
11,993
|
10,410
|
Current
portion of operating lease liability (note 8)
|
1,360
|
-
|
Total
current liabilities
|
53,401
|
46,140
|
Long-term
operating lease liability (note 8)
|
3,190
|
-
|
Other
long-term liabilities (note 9)
|
3,963
|
4,583
|
Total
liabilities
|
60,554
|
50,723
|
Commitments and contingencies (note 16)
|
|
|
Stockholders’
equity:
|
|
|
Common
stock – Class A, par value $0.0001: 50,000,000 shares
authorized as of June 30, 2019 and December 31, 2018. 14,229,942
shares issued and outstanding as of June 30, 2019 and 14,110,315
shares issued and outstanding as of December 31, 2018 (note
13)
|
1
|
1
|
Common
stock–Class B, par value $0.0001: 2,409,738 shares authorized
as of June 30, 2019 and December 31, 2018. 1,883,423 shares issued
and outstanding as of June 30, 2019 and 1,898,423 shares issued and
outstanding as of December 31, 2018 (note 13)
|
-
|
-
|
Additional
paid in capital
|
58,101
|
56,567
|
Accumulated
surplus (deficit)
|
2,781
|
(3,387)
|
Accumulated
other comprehensive loss
|
(1,168)
|
(857)
|
Total
stockholders’ equity
|
59,715
|
52,324
|
Total
liabilities and stockholders’ equity
|
$120,269
|
$103,047
|
The accompanying notes are an integral part of these condensed
consolidated financial statements.
3
ACM RESEARCH, INC.
Condensed Consolidated Statements of Operations and Comprehensive
Income
(In thousands, except share and per share data)
(Unaudited)
|
Three Months
Ended June 30,
|
Six Months Ended
June 30,
|
||
|
2019
|
2018
|
2019
|
2018
|
Revenue
|
$29,010
|
$20,873
|
$49,489
|
$30,616
|
Cost of revenue
|
15,879
|
12,149
|
27,532
|
16,770
|
Gross profit
|
13,131
|
8,724
|
21,957
|
13,846
|
Operating expenses:
|
|
|
|
|
Sales and marketing
|
2,924
|
2,682
|
4,793
|
4,537
|
Research and development
|
3,341
|
2,419
|
6,106
|
3,960
|
General and administrative
|
2,205
|
1,292
|
4,146
|
4,922
|
Total operating expenses, net
|
8,470
|
6,393
|
15,045
|
13,419
|
Income
from operations
|
4,661
|
2,331
|
6,912
|
427
|
Interest income
|
24
|
14
|
33
|
17
|
Interest expense
|
(194)
|
(149)
|
(333)
|
(252)
|
Other
income, net
|
543
|
1,066
|
282
|
311
|
Equity income in net income of affiliates
|
153
|
117
|
269
|
118
|
Income before income taxes
|
5,187
|
3,379
|
7,163
|
621
|
Income tax expense (note 15)
|
(876)
|
(164)
|
(995)
|
(186)
|
Net
income
|
$4,311
|
$3,215
|
$6,168
|
$435
|
Comprehensive income:
|
|
|
|
|
Net income
|
4,311
|
3,215
|
6,168
|
435
|
Foreign currency translation adjustment
|
(968)
|
(1,036)
|
(311)
|
(331)
|
Total comprehensive
Income (note 2)
|
$3,343
|
$2,179
|
$5,857
|
$104
|
|
|
|
|
|
Net income
per common share (note 2):
|
|
|
|
|
Basic
|
$0.27
|
$0.20
|
$0.38
|
$0.03
|
Diluted
|
$0.23
|
$0.18
|
$0.33
|
$0.02
|
|
|
|
|
|
Weighted
average common shares outstanding used in computing per share amounts (note 2):
|
|
|
||
Basic
|
16,090,937
|
15,838,540
|
16,067,924
|
15,611,863
|
Diluted
|
18,604,347
|
18,119,733
|
18,455,534
|
17,669,650
|
The accompanying notes are an integral part of these condensed
consolidated financial statements.
4
ACM RESEARCH, INC.
Condensed Consolidated Statements of Changes in Stockholders’
Equity
For the Three Months Ended June 30, 2019 and 2018
(In thousands, except share and per share data)
(Unaudited)
|
Common
|
Common
|
|
|
|
|
||
|
Stock
Class A
|
Stock
Class B
|
|
|
|
|
||
|
Shares
|
Amount
|
Shares
|
Amount
|
Additional
Paid-in Capital
|
Accumulated
Surplus (Deficit)
|
Accumulated
Other Comprehensive Loss
|
Total
Stockholders’ Equity
|
Balance
at April 1, 2019
|
14,176,690
|
$1
|
1,898,423
|
$-
|
$57,371
|
$(1,530)
|
$(200)
|
$55,642
|
Net
income
|
-
|
-
|
-
|
-
|
-
|
4,311
|
-
|
4,311
|
Foreign currency
translation adjustment
|
-
|
-
|
-
|
-
|
-
|
-
|
(968)
|
(968)
|
Exercise of stock
option
|
38,252
|
-
|
-
|
-
|
112
|
-
|
-
|
112
|
Stock-based
compensation
|
-
|
-
|
-
|
-
|
618
|
-
|
-
|
618
|
Conversion of class B
common shares to Class A common shares
|
15,000
|
-
|
(15,000)
|
-
|
-
|
-
|
-
|
-
|
Balance
at June 30, 2019
|
14,229,942
|
$1
|
1,883,423
|
$-
|
$58,101
|
$2,781
|
$(1,168)
|
$59,715
|
|
Common
|
Common
|
|
|
|
|
||
|
Stock Class A
|
Stock Class B
|
|
|
|
|
||
|
Shares
|
Amount
|
Shares
|
Amount
|
Additional Paid-in Capital
|
Accumulated Surplus (Deficit)
|
Accumulated Other Comprehensive Income (Loss)
|
Total Stockholders’ Equity
|
Balance at April 1, 2018
|
13,390,270
|
$1
|
2,409,738
|
$-
|
54,915
|
$(12,741)
|
827
|
43,002
|
Net
income
|
-
|
-
|
-
|
-
|
-
|
3,215
|
-
|
3,215
|
Foreign
currency translation adjustment
|
-
|
-
|
-
|
-
|
-
|
-
|
(1,036)
|
(1,036)
|
Exercise of
stock option
|
77,504
|
-
|
-
|
-
|
231
|
-
|
-
|
231
|
Stock-based
compensation
|
-
|
-
|
-
|
-
|
185
|
-
|
-
|
185
|
Conversion of
class B common shares to Class A common shares
|
489,565
|
-
|
(489,565)
|
-
|
-
|
-
|
-
|
-
|
Balance at June 30, 2018
|
13,957,339
|
$1
|
1,920,173
|
$-
|
55,331
|
$(9,526)
|
$(209)
|
45,597
|
The accompanying notes are an integral part of these condensed
consolidated financial statements.
5
ACM RESEARCH, INC.
Condensed Consolidated Statements of Changes in Stockholders’
Equity (Continued)
For the Six Months Ended June 30, 2019 and 2018
(In thousands, except share and per share data)
(Unaudited)
|
Common
Stock Class A
|
Common
Stock Class B
|
|
|
|
|
||
|
Shares
|
Amount
|
Shares
|
Amount
|
Additional Paid-in Capital
|
Accumulated Surplus (Deficit)
|
Accumulated Other Comprehensive Loss
|
Total Stockholders’ Equity
|
Balance at January 1, 2019
|
14,110,315
|
$1
|
1,898,423
|
$-
|
$56,567
|
$(3,387)
|
$(857)
|
$52,324
|
Net
income
|
-
|
-
|
-
|
-
|
-
|
6,168
|
-
|
6,168
|
Foreign
currency translation adjustment
|
-
|
-
|
-
|
-
|
-
|
-
|
(311)
|
(311)
|
Exercise of
stock option
|
104,627
|
-
|
-
|
-
|
172
|
-
|
-
|
172
|
Stock-based
compensation
|
-
|
-
|
-
|
-
|
1,362
|
-
|
-
|
1,362
|
Conversion of
class B common shares to Class A common shares
|
15,000
|
-
|
(15,000)
|
-
|
-
|
-
|
-
|
-
|
Balance at June 30, 2019
|
14,229,942
|
$1
|
1,883,423
|
$-
|
$58,101
|
$2,781
|
$(1,168)
|
$59,715
|
|
Common
Stock
Class A
|
Common
Stock
Class B
|
|
|
|
|
||
|
Shares
|
Amount
|
Shares
|
Amount
|
Additional
Paid-in Capital
|
Accumulated
Surplus (Deficit)
|
Accumulated
Other Comprehensive Income (Loss)
|
Total
Stockholders’ Equity
|
Balance
at January 1, 2018
|
12,935,546
|
$1
|
2,409,738
|
$-
|
49,695
|
$(9,961)
|
122
|
39,857
|
Net
income
|
-
|
-
|
-
|
-
|
-
|
435
|
-
|
435
|
Foreign currency
translation adjustment
|
-
|
-
|
-
|
-
|
-
|
-
|
(331)
|
(331)
|
Exercise of stock
option
|
134,726
|
-
|
-
|
-
|
295
|
-
|
-
|
295
|
Stock-based
compensation
|
-
|
-
|
-
|
-
|
2,360
|
-
|
-
|
2,360
|
Conversion of class B
common shares to Class A common shares
|
489,565
|
-
|
(489,565)
|
-
|
-
|
-
|
-
|
-
|
Exercise of common
stock warrant issued to SMC
|
397,502
|
-
|
-
|
-
|
2,981
|
-
|
-
|
2,981
|
Balance
at June 30, 2018
|
13,957,339
|
$1
|
1,920,173
|
$-
|
55,331
|
$(9,526)
|
$(209)
|
45,597
|
The accompanying notes are an integral part of these condensed
consolidated financial statements.
6
ACM RESEARCH, INC.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
|
Six Months Ended
June 30,
|
|
|
2019
|
2018
|
Cash
flows from operating activities:
|
|
|
Net
income
|
$6,168
|
$435
|
Adjustments to
reconcile net income from operations to net cash used
in
|
|
|
operating
activities:
|
|
|
Depreciation
and amortization
|
388
|
173
|
Loss
on disposals of property, plant and equipment
|
299
|
|
Equity
income in net income of affiliates
|
(269)
|
(118)
|
Deferred
income taxes
|
(1)
|
-
|
Stock-based
compensation
|
1,362
|
2,360
|
Net
changes in operating assets and liabilities:
|
|
|
Accounts
receivable
|
(6,837)
|
(6,858)
|
Other
receivables
|
1,150
|
1,124
|
Inventory
|
(6,783)
|
(12,328)
|
Prepaid
expenses
|
412
|
(1,785)
|
Other
long-term assets
|
(223)
|
46
|
Accounts
payable
|
1,600
|
10,486
|
Advances
from customers
|
(2,703)
|
1,799
|
Income
tax payable
|
(1,011)
|
187
|
Other
payables and accrued expenses
|
2,453
|
632
|
Other
long-term liabilities
|
(612)
|
(271)
|
Net
cash used in operating activities
|
(4,607)
|
(4,118)
|
|
|
|
Cash
flows from investing activities:
|
|
|
Purchase of
property and equipment
|
(325)
|
(882)
|
Purchase of
intangible assets
|
(71)
|
(157)
|
Investments in
unconsolidated affiliates
|
(109)
|
|
Net
cash used in investing activities
|
(505)
|
(1,039)
|
|
|
|
Cash
flows from financing activities:
|
|
|
Proceeds from
short-term borrowings
|
15,023
|
10,153
|
Repayments of
short-term borrowings
|
(9,346)
|
(5,252)
|
Proceeds from stock
option exercise to common stock
|
172
|
295
|
Net
cash provided by financing activities
|
5,849
|
5,196
|
|
|
|
Effect
of exchange rate changes on cash and cash equivalents
|
$(283)
|
$(285)
|
Net (decrease)
increase in cash and cash equivalents
|
$454
|
$(246)
|
|
|
|
Cash and cash
equivalents at beginning of period
|
27,124
|
17,681
|
Cash
and cash equivalents at end of period
|
$27,578
|
$17,435
|
|
|
|
Supplemental
disclosure of cash flow information:
|
|
|
Interest
paid
|
$333
|
$252
|
The accompanying notes are an integral part of these condensed
consolidated financial statements
7
ACM RESEARCH, INC.
Notes to Condensed Consolidated
Financial Statements (unaudited)
(in thousands, except share and per share data)
NOTE 1 – DESCRIPTION OF BUSINESS
ACM
Research, Inc. (“ACM”) and its subsidiaries
(collectively with ACM, the “Company”) develop,
manufacture and sell single-wafer wet cleaning equipment used to
improve the manufacturing process and yield for advanced integrated
chips. The Company markets and sells its single-wafer wet-cleaning
equipment, under the brand name “Ultra C,” based on the
Company’s proprietary Space Alternated Phase Shift
(“SAPS”) and Timely Energized Bubble Oscillation
(“TEBO”) technologies. These tools are designed to
remove random defects from a wafer surface efficiently, without
damaging the wafer or its features, even at increasingly advanced
process nodes.
ACM was
incorporated in California in 1998, and it initially focused on
developing tools for manufacturing process steps involving the
integration of ultra low-K materials and copper. The
Company’s early efforts focused on stress-free
copper-polishing technology, and it sold tools based on that
technology in the early 2000s.
In 2006
the Company established its operational center in Shanghai in the
People’s Republic of China (the “PRC”), where it
operates through ACM’s subsidiary ACM Research (Shanghai),
Inc. (“ACM Shanghai”). ACM Shanghai was formed to help
establish and build relationships with integrated circuit
manufacturers in the PRC, and the Company initially financed its
Shanghai operations in part through sales of non-controlling equity
interests in ACM Shanghai.
In 2007
the Company began to focus its development efforts on single-wafer
wet-cleaning solutions for the front-end chip fabrication process.
The Company introduced its SAPS megasonic technology, which can be
applied in wet wafer cleaning at numerous steps during the chip
fabrication process, in 2009. It introduced its TEBO technology,
which can be applied at numerous steps during the fabrication of
small node two-dimensional conventional and three-dimensional
patterned wafers, in March 2016. The Company has designed its
equipment models for SAPS and TEBO solutions using a modular
configuration that enables it to create a wet-cleaning tool meeting
the specific requirements of a customer, while using pre-existing
designs for chamber, electrical, chemical delivery and other
modules. In August 2018, the Company introduced its Ultra-C Tahoe
wafer cleaning tool, which can deliver high cleaning performance
with significantly less sulfuric acid than typically consumed by
conventional high-temperature single-wafer cleaning tools. The
Company also offers a range of custom-made equipment, including
cleaners, coaters and developers, to back-end wafer assembly and
packaging factories, principally in the PRC.
In 2011
ACM Shanghai formed a wholly owned subsidiary in the PRC, ACM
Research (Wuxi), Inc. (“ACM Wuxi”), to manage sales and
service operations.
In
November 2016 ACM redomesticated from California to Delaware
pursuant to a merger in which ACM Research, Inc., a California
corporation, was merged into a newly formed, wholly owned Delaware
subsidiary, also named ACM Research, Inc.
In June
2017 ACM formed a wholly owned subsidiary in Hong Kong, CleanChip
Technologies Limited (“CleanChip”), to act on the
Company’s behalf in Asian markets outside the PRC by, for
example, serving as a trading partner between ACM Shanghai and its
customers, procuring raw materials and components, performing sales
and marketing activities, and making strategic
investments.
In
August 2017 ACM purchased 18.77% of ACM Shanghai’s equity
interests held by Shanghai Science and Technology Venture Capital
Co., Ltd. On November 8, 2017, ACM purchased the remaining 18.36%
of ACM Shanghai’s equity interest held by third parties,
Shanghai Pudong High-Tech Investment Co., Ltd.
(“PDHTI”) and Shanghai Zhangjiang Science &
Technology Venture Capital Co., Ltd. (“ZSTVC”). At
December 31, 2017, ACM owned all of the outstanding equity
interests of ACM Shanghai, and indirectly through ACM Shanghai,
owned all of the outstanding equity interests of ACM
Wuxi.
On
September 13, 2017, ACM effectuated a 1-for-3 reverse stock split
of Class A and Class B common stock. Unless otherwise indicated,
all share numbers, per share amount, share prices, exercise prices
and conversion rates set forth in these notes and the accompanying
condensed consolidated financial statements have been adjusted
retrospectively to reflect the reverse stock split.
In
December 2017 ACM formed a wholly owned subsidiary in the Republic
of Korea, ACM Research Korea CO., LTD. (“ACM Korea”),
to serve customers based in Republic of Korea and perform sales,
marketing, research and development activities for new products and
solutions.
On June
17, 2019 ACM announced plans to complete over the next three years
a listing (the “Listing”) of shares of ACM Shanghai on
the Shanghai Stock Exchange’s new Sci-Tech innovAtion boaRd,
known as the STAR Market, and a concurrent initial public offering
(the “IPO”), of ACM Shanghai shares in the PRC. ACM
Shanghai is currently our principal operating company and a
wholly-owned subsidiary of ACM Research. Following the Listing and
IPO, ACM Shanghai will be a majority-owned subsidiary of ACM
Research.
8
ACM RESEARCH, INC.
Notes to Condensed Consolidated Financial Statements
(unaudited)
(in thousands, except share and per share data)
As an
initial step in qualifying for the Listing and IPO, on June 12,
2019 ACM Shanghai entered into agreements with seven investors
pursuant to which those investors agreed to pay a purchase price
totaling RMB 187.9 million (equivalent to $27.3 million) to ACM
Shanghai for shares representing 4.2% of the then-outstanding ACM
Shanghai shares. Pursuant to these agreements, the investors are
obligated to fund their purchases (see note 17) after ACM Shanghai
made the required filings for the capital increase with the local
agency of the PRC Ministry of Commerce. Once it has received
payment of the purchase prices from all of the parties, ACM
Shanghai is obligated to process necessary PRC governmental
registrations for the capital increase with the local branch of the
PRC State Administration for Market Regulation. Upon completion of
those registrations, the investors will be regarded as the owners
of their subscribed shares.
In
March 2019, ACM Shanghai formed a wholly owned subsidiary in the
PRC, Shengwei Research (Shanghai), Inc., to manage activities
related to addition of future long-term production capacity. The
subsidiary was formed with registered capital of RMB 5.0 million
($727). As of June 30, 2019, no capital had been injected in this
new subsidiary.
NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation and Principles of Consolidation
The
consolidated accounts include ACM and its subsidiaries ACM
Shanghai, ACM Wuxi, CleanChip and ACM Korea. Subsidiaries are those
entities in which ACM, directly and indirectly, controls more than
one half of the voting power. All significant intercompany
transactions and balances have been eliminated upon
consolidation.
The
accompanying condensed consolidated financial statements of the
Company have been prepared in accordance with accounting principles
generally accepted in the United States of America
(“GAAP”) for interim financial information and the
rules and regulations of the SEC for reporting on Form 10-Q.
Accordingly, they do not include all the information and footnotes
required by GAAP for complete financial statements herein. The
unaudited condensed consolidated financial statements herein should
be read in conjunction with the historical consolidated financial
statements of the Company for the year ended December 31, 2018
included in the Company’s Annual Report on Form 10-K for the
year ended December 31, 2018.
The
accompanying condensed consolidated balance sheet as of June 30,
2019, the condensed consolidated statements of operations and
comprehensive income for the three and six months ended June 30,
2019 and 2018, the condensed consolidated statements of changes in
stockholders’ equity for the six months ended June 30, 2019
and 2018, and the condensed consolidated statements of cash flows
for the six months ended June 30, 2019 and 2018 are unaudited. In
the opinion of management, the unaudited condensed consolidated
financial statements of the Company reflect all adjustments that
are necessary for a fair presentation of the Company’s
financial position and results of operations. Such adjustments are
of a normal recurring nature, unless otherwise noted. The balance
sheet as of June 30, 2019 and the results of operations for the
three and six months ended June 30, 2019 are not necessarily
indicative of the results to be expected for any future
period.
Use of Estimates
The
preparation of condensed consolidated financial statements in
conformity with GAAP requires management to make estimates and
assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at
the balance sheet date and the reported revenue and expenses during
the reported period in the condensed consolidated financial
statements and accompanying notes. The Company’s significant
accounting estimates and assumptions include, but are not limited
to, those used for the valuation and recognition of stock-based
compensation arrangements and warrant liability, realization of
deferred tax assets, assessment for impairment of long-lived
assets, allowance for doubtful accounts, inventory valuation for
excess and obsolete inventories, lower of cost and market value or
net realizable value of inventories, depreciable lives of property
and equipment, and useful life of intangible assets. Management of
the Company believes that the estimates, judgments and assumptions
are reasonable, based on information available at the time they are
made. Actual results could differ materially from those
estimates.
9
ACM RESEARCH, INC.
Notes to Condensed Consolidated
Financial Statements (unaudited)
(in thousands, except share and per share data)
Basic and Diluted Net Income per Common Share
Basic
and diluted net income per common share is calculated as
follows:
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
||
|
2019
|
2018
|
2019
|
2018
|
Numerator:
|
|
|
|
|
Net income
|
$4,311
|
$3,215
|
$6,168
|
$435
|
Denominator:
|
|
|
|
|
Weighted average shares outstanding, basic
|
16,090,937
|
15,838,540
|
16,067,924
|
15,611,863
|
Effect of dilutive securities
|
2,513,410
|
2,281,193
|
2,387,610
|
2,057,787
|
Weighted average shares outstanding, diluted
|
18,604,347
|
18,119,733
|
18,455,534
|
17,669,650
|
Net
income per common share:
|
|
|
|
|
Basic
|
$0.27
|
$0.20
|
$0.38
|
$0.03
|
Diluted
|
$0.23
|
$0.18
|
$0.33
|
$0.02
|
ACM has
been authorized to issue Class A and Class B common stock since
redomesticating in Delaware in November 2016. The two classes of
common stock are substantially identical in all material respects,
except for voting rights. Since ACM did not declare any dividends
during the three and six months ended June 30, 2019 and 2018, the
net income per common share attributable to each class is the same
under the “two-class” method. As such, the two classes
of common stock have been presented on a combined basis in the
condensed consolidated statements of operations and comprehensive
income and in the above computation of net income per common
share.
Diluted
net income per common share reflects the potential dilution from
securities that could share in ACM’s earnings. ACM’s
potential dilutive securities consist warrants and stock options
for the three and six months ended June 30, 2019 and 2018.
Certain potential dilutive securities
were excluded from the net income per share calculation because the
impact would be anti-dilutive.
Recent Accounting Pronouncements
Recently Adopted Accounting Pronouncements
In
February 2016, the Financial Accounting Standards Board
(“FASB”) issued Accounting Standards Update
(“ASU”) 2016-02, Leases (Topic 842). The amendments in
ASU 2016-02 create Topic 842,
Leases, and supersede the
leases requirements in Topic 840, Leases. Topic 842 specifies the
accounting for leases. The objective of Topic 842 is to establish
the principles that lessees and lessors shall apply to report
useful information to users of financial statements about the
amount, timing, and uncertainty of cash flows arising from a lease.
The main difference between Topic 842 and Topic 840 is the
recognition of lease assets and lease liabilities for those leases
classified as operating leases under Topic 840. Topic 842 retains a
distinction between finance leases and operating leases. The
classification criteria for distinguishing between finance leases
and operating leases are substantially similar to the
classification criteria for distinguishing between capital leases
and operating leases in the previous lease guidance. The result of
retaining a distinction between finance leases and operating leases
is that under the lessee accounting model in Topic 842, the effect
of leases in the statement of comprehensive income and the
statement of cash flows is largely unchanged from previous
GAAP.
Effective January
1, 2019, the Company adopted ASU 2016-02. The original guidance
required application on a modified retrospective basis with the
earliest period presented. In August 2018, the FASB issued ASU
2018-11, Targeted Improvements to
ASC 842, Leases,
which included an option to not restate comparative periods in
transition and elect to use the effective date of Accounting
Standards Codification (“ASC”) 842 as the date of initial
application of transition, which the Company elected. As a result
of its adoption of ASC 842 as of January 1, 2019, the Company
recorded operating lease right-of-use assets of $5,109 and lease
liabilities of $5,109. The adoption of ASC 842 had no impact on the
Company’s profit or cash flows for the three and six month
period ended June 30, 2019. In addition, the Company elected the
package of practical expedients permitted under the transition
guidance within the new standard, which allowed the Company to
carry forward the historical lease classification. Additional
information and disclosures required by this new standard are
contained in note 8.
10
ACM RESEARCH, INC.
Notes to Condensed Consolidated
Financial Statements (unaudited)
(in thousands, except share and per share data)
In June
2018, the FASB issued ASU 2018-07, Compensation—Stock Compensation (Topic
718)—Improvements to Nonemployee Share-Based Payment
Accounting, which simplifies several aspects of the
accounting for nonemployee share-based payment transactions
resulting from expanding the scope of Topic 718, Compensation—Stock Compensation,
to include share-based payment transactions for acquiring goods and
services from nonemployees. Some of the areas for simplification
apply only to nonpublic entities. ASU 2018-07 specifies that Topic
718 applies to all share-based payment transactions in which a
grantor acquires goods or services to be used or consumed in a
grantor’s own operations by issuing share-based payment
awards. ASU 2018-07 also clarifies that Topic 718 does not apply to
share-based payments used to effectively provide (1) financing to
the issuer or (2) awards granted in conjunction with selling goods
or services to customers as part of a contract accounted for under
the new revenue recognition standard set forth in ASU 2014-09,
Revenue from Contracts with
Customers (Topic 606). Effective January 1, 2019, the
Company adopted ASU 2018-07, which did not have a material impact
on the Company’s consolidated financial
statements.
Recent Accounting Pronouncements Not Yet Adopted
In
August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820),
which eliminates, adds and modifies certain disclosure requirements
for fair value measurements. The modified standard eliminates the
requirement to disclose changes in unrealized gains and losses
included in earnings for recurring Level 3 fair value measurements
and requires changes in unrealized gains and losses be included in
other comprehensive income for recurring Level 3 fair value
measurements of instruments. The standard also requires the
disclosure of the range and weighted average used to develop
significant unobservable inputs and how weighted average is
calculate for recurring and nonrecurring Level 3 fair value
measurements. The amendment is effective for fiscal years beginning
after December 15, 2019 and interim periods within that fiscal
year, with early adoption permitted. The Company is evaluating the
impact of the adoption of ASU 2018-13 on its consolidated financial
statements.
In
January 2017, the FASB issued ASU 2017-04, Intangibles—Goodwill and Other (Topic
350): Simplifying the Test for Goodwill Impairment, which
removes Step 2 from the goodwill impairment test. An entity will
apply a one-step quantitative test and record the amount of
goodwill impairment as the excess of a reporting unit’s
carrying amount over its fair value, not to exceed the total amount
of goodwill allocated to the reporting unit. ASU 2017-04 does not amend the optional
qualitative assessment of goodwill impairment. A business entity
that files periodic reports with the Securities and Exchange
Commission must adopt the amendments in ASU 2017-04 for its annual or any interim
goodwill impairment test in fiscal years beginning after December
15, 2019. Early adoption is permitted for interim or annual
goodwill impairment tests performed on testing dates after January
1, 2017. The Company is evaluating the impact of the adoption of
ASU 2017-04 on its consolidated financial statements.
In June
2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic
326): Measurement of Credit Losses on Financial Instruments.
ASU 2016-13 replaced the incurred loss impairment methodology under
current GAAP with a methodology that reflects expected credit
losses and requires consideration of a broader range of reasonable
and supportable information to inform credit loss estimates. ASU
2016-13 requires use of a forward-looking expected credit loss
model for accounts receivables, loans, and other financial
instruments. ASU 2016-13 is effective for fiscal years beginning
after December 15, 2019, with early adoption permitted. Adoption of
the standard requires using a modified retrospective approach
through a cumulative-effect adjustment to retained earnings as of
the effective date to align existing credit loss methodology with
the new standard. The Company will adopt ASU 2016-13 effective
January 1, 2020. The Company is evaluating the impact of this
standard on its consolidated financial statements, including
accounting policies, processes, and systems, but does not expect
the standard will have a material impact on its consolidated
financial statements.
NOTE 3 – ACCOUNTS RECEIVABLE
At June
30, 2019 and December 31, 2018, accounts receivable consisted of
the following:
|
June 30,
|
December 31,
|
|
2019
|
2018
|
Accounts receivable
|
$31,393
|
$24,608
|
Less: Allowance for doubtful accounts
|
-
|
-
|
Total
|
$31,393
|
$24,608
|
The
Company reviews accounts receivable on a periodic basis and makes
general and specific allowances when there is doubt as to the
collectability of individual balances. No allowance for doubtful
accounts was considered necessary at June 30, 2019 or December 31,
2018. At June 30, 2019 and December
31, 2018, accounts receivable of $0 and $1,457,
respectively, were pledged as
collateral for borrowings from financial
institutions.
11
ACM RESEARCH, INC.
Notes to Condensed Consolidated
Financial Statements (unaudited)
(in thousands, except share and per share data)
NOTE 4 – INVENTORIES
At June
30, 2019 and December 31, 2018, inventory consisted of the
following:
|
June 30,
2019
|
December 31,
2018
|
Raw materials
|
$17,425
|
$12,646
|
Work in process
|
15,103
|
9,631
|
Finished goods
|
12,966
|
16,487
|
Total inventory, gross
|
45,494
|
38,764
|
Inventory reserve
|
-
|
-
|
Total inventory, net
|
$45,494
|
$38,764
|
At June
30, 2019 and December 31, 2018, the Company did not have an
inventory reserve and no inventory was pledged as collateral for
borrowings from financial institutions. System shipments of
first-tools to an existing or prospective customer, for which
ownership does not transfer until customer acceptance, are
classified as finished goods inventory and carried at cost until
ownership is transferred.
NOTE 5 – PROPERTY, PLANT AND EQUIPMENT, NET
At June
30, 2019 and December 31, 2018, property, plant and equipment
consisted of the following:
|
June 30,
|
December 31,
|
|
2019
|
2018
|
Manufacturing equipment
|
$3,948
|
$9,703
|
Office equipment
|
601
|
512
|
Transportation equipment
|
126
|
184
|
Leasehold improvement
|
1,424
|
1,379
|
Total cost
|
6,099
|
11,778
|
Less: Total accumulated depreciation
|
(2,831)
|
(8,102)
|
Construction in progress
|
108
|
32
|
Total property, plant and equipment, net
|
$3,376
|
$3,708
|
Depreciation
expense was $177 and $88 for the three months ended June 30, 2019
and 2018, respectively, and $352 and $173 for the six months ended
June 30, 2019 and 2018, respectively.
12
ACM RESEARCH, INC.
Notes to Condensed Consolidated
Financial Statements (unaudited)
(in thousands, except share and per share data)
NOTE 6 – SHORT-TERM BORROWINGS
At June
30, 2019 and December 31, 2018, short-term borrowings consisted of
the following:
|
June 30,
2019
|
December 31,
2018
|
Line
of credit up to RMB 50,000 from Bank of Shanghai Pudong Branch, due
on April 17,2019 with an annual interest rate of 4.99%, guaranteed
by the Company’s CEO and fully repaid on March 27,
2019.
|
$-
|
$3,133
|
Line
of credit up to RMB 50,000 from Bank of Shanghai Pudong Branch, due
on February 14,2019 with an annual interest rate of 5.15%,
guaranteed by the Company’s CEO and fully repaid on February
14, 2019.
|
-
|
485
|
Line
of credit up to RMB 50,000 from Bank of Shanghai Pudong Branch, due
on January 23, 2020 with an annual interest rate of 5.22%,
guaranteed by the Company’s CEO and Cleanchip Technologies
Limited.
|
3,565
|
|
Line of credit up to RMB 30,000 from Bank of China
Pudong Branch, due on June 6,2019 with annual interest rate of
5.22%,secured by certain of the Company’s intellectual
property and the Company’s CEO and fully repaid on
June 6,2019.
|
-
|
2,186
|
Line
of credit up to RMB 30,000 from Bank of China Pudong Branch, due on
June 13,2019 with annual interest rate of 5.22%,secured by certain
of the Company’s intellectual property and the
Company’s CEO and fully repaid on June 13,2019.
|
-
|
2,186
|
Line
of credit up to RMB 10,000 from Shanghai Rural Commercial Bank, due
on January 23, 2019 with an annual interest rate of 5.44%,
guaranteed by the Company’s CEO and pledged by accounts
receivable,and fully repaid on January 23, 2019.
|
-
|
1,457
|
Line
of credit up to RMB 20,000 from Shanghai Rural Commercial Bank, due
on February 21, 2020 with an annual interest rate of 5.66%,
guaranteed by the Company’s CEO and pledged by accounts
receivable.
|
1,455
|
|
Line
of credit up to RMB 20,000 from Bank of Communications, due on
January 18, 2020 with an annual interest rate of
5.66%.
|
1,455
|
|
Line
of credit up to RMB 20,000 from Bank of Communications, due on
January 22, 2020 with an annual interest rate of
5.66%.
|
728
|
|
Line
of credit up to RMB 20,000 from Bank of Communications, due on
February 14, 2020 with an annual interest rate of
5.66%.
|
728
|
|
Line
of credit up to RMB 50,000 from China Everbright Bank, due on March
25, 2020 with an annual interest rate of 4.94%, guaranteed by the
Company’s CEO.
|
3,251
|
|
Line
of credit up to RMB 50,000 from China Everbright Bank, due on April
17, 2020 with an annual interest rate of 5.66%, guaranteed by the
Company’s CEO.
|
1,164
|
|
Line
of credit up to RMB 50,000 from China Everbright Bank, due on June
26, 2020 with an annual interest rate of 5.66%, guaranteed by the
Company’s CEO.
|
2,764
|
|
Total
|
$15,110
|
$9,447
|
Interest
expense related to short-term borrowings amounted to $194 and $149
for the three months ended June 30, 2019 and 2018, respectively,
and $333 and $252 for the six months ended June 30, 2019 and 2018,
respectively.
13
ACM RESEARCH, INC.
Notes to Condensed Consolidated
Financial Statements (unaudited)
(in thousands, except share and per share data)
NOTE 7 – OTHER PAYABLE AND ACCRUED EXPENSES
At June
30, 2019 and December 31, 2018, other payable and accrued expenses
consisted of the following:
|
June 30,
2019
|
December 31,
2018
|
Lease expenses and payable for leasehold improvement due to a related party (note 11)
|
$52
|
$53
|
Accrued
commissions
|
2,455
|
2,931
|
Accrued warranty
|
2,338
|
1,710
|
Accrued payroll
|
1,392
|
626
|
Accrued professional fees
|
234
|
64
|
Accrued machine testing fees
|
2,859
|
3,076
|
Others
|
2,663
|
1,950
|
Total
|
$11,993
|
$10,410
|
NOTE 8 –LEASES
The
Company leases space under non-cancelable operating leases for
several office and manufacturing locations. These leases do not
have significant rent escalation holidays, concessions, leasehold
improvement incentives, or other build-out clauses. Further, the
leases do not contain contingent rent provisions.
Most
leases include one or more options to renew. The exercise of lease
renewal options is typically at the Company’s sole
discretion; therefore, the majority of renewals to extend the lease
terms are not included in the Company’s right-of-use assets
and lease liabilities as they are not reasonably certain of
exercise. The Company regularly evaluates the renewal options, and
when they are reasonably certain of exercise, the Company includes
the renewal period in its lease term.
As most
of the Company’s leases do not provide an implicit rate, the
Company uses its incremental borrowing rate based on the
information available at the lease commencement date in determining
the present value of the lease payments. The Company has a
centrally managed treasury function; therefore, based on the
applicable lease terms and the current economic environment, it
applies a portfolio approach for determining the incremental
borrowing rate.
The
components of lease expense were as follows:
|
Three
months
ended
June
30,
2019
|
Six
months
ended
June
30,
2019
|
Operating lease
cost
|
$264
|
$701
|
Short-term lease
cost
|
7
|
25
|
Lease
cost
|
$271
|
$726
|
Supplemental cash
flow information related to operating leases was as follows for the
period ended June 30, 2019:
|
Three
months
ended
June
30,
2019
|
Six
months
ended
June
30,
2019
|
Cash paid for
amounts included in the measurement of lease
liabilities:
|
|
|
Operating
cash outflow from operating leases
|
271
|
726
|
14
ACM RESEARCH, INC.
Notes to Condensed Consolidated
Financial Statements (unaudited)
(in thousands, except share and per share data)
Maturities of lease
liabilities for all operating leases were as follows as of June 30,
2019:
|
December 31
|
2019
|
$728
|
2020
|
1,488
|
2021
|
1,475
|
2022
|
1,495
|
2023
|
53
|
2024
|
13
|
Total lease
payments
|
5,252
|
Less:
Interest
|
(702)
|
Present value of
lease liabilities
|
$4,550
|
The
weighted average remaining lease terms and discount rates for all
operating leases were as follows as of June 30, 2019:
|
June
30,
2019
|
Remaining lease
term and discount rate:
|
|
Weighted average
remaining lease term (years)
|
3.50
|
Weighted average
discount rate
|
5.43%
|
NOTE 9 – OTHER LONG-TERM LIABILITIES
Other
long-term liabilities represent government subsidies received from
PRC governmental authorities for development and commercialization
of certain technology but not yet recognized. As of June 30, 2019,
and December 31, 2018, other long-term liabilities consisted of the
following unearned government subsidies:
|
June 30,
2019
|
December 31,
2018
|
Subsidies to Stress Free Polishing project, commenced in 2008 and 2017
|
$1,362
|
$1,483
|
Subsidies to Electro Copper Plating project, commenced in 2014
|
2,370
|
2,860
|
Subsidies to Polytetrafluoroethylene, commenced in 2018
|
158
|
178
|
Other
|
73
|
62
|
Total
|
$3,963
|
$4,583
|
NOTE 10 – LONG-TERM INVESTMENT
On
September 6, 2017, ACM and Ninebell Co., Ltd.
(“Ninebell”), a Korean company that is one of the
Company’s principal materials suppliers, entered into an
ordinary share purchase agreement, effective as of September 11,
2017, pursuant to which Ninebell issued to ACM ordinary shares
representing 20% of Ninebell’s post-closing equity for a
purchase price of $1,200, and a common stock purchase agreement,
effective as of September 11, 2017, pursuant to which ACM issued
133,334 shares of Class A common stock to Ninebell for a purchase
price of $1,000 at $7.50 per share.
The investment in Ninebell is accounted for under the equity
method.
On June 27, 2019, ACM Shanghai and Shengyi
Semiconductor Technology Co., Ltd. (“Shengyi”), a
company based in Wuxi, China that is one of the Company’s
components suppliers, entered into an agreement pursuant to which
Shengyi issued to ACM Shanghai shares representing 15% of
Shengyi’s post-closing equity for a purchase price of $109.
The investment in Shengyi is accounted for under the cost
method.
|
June 30,
2019
|
December 31,
2018
|
Investment
– equity method
|
$1,629
|
$1,360
|
Investment
– cost method
|
109
|
-
|
Total
|
$1,738
|
$1,360
|
15
ACM
RESEARCH, INC.
Notes to Condensed Consolidated
Financial Statements (unaudited)
(in thousands, except share and per share data)
NOTE 11– RELATED PARTY BALANCES AND TRANSACTIONS
On
August 18, 2017, ACM and Ninebell, its equity method investment
affiliate (note 10), entered into a loan agreement pursuant to
which ACM made an interest-free loan of $946 to Ninebell, payable
in 180 days or automatically extended another 180 days if in
default. The loan was secured by a pledge of Ninebell’s
accounts receivable due from ACM and all money that Ninebell
received from
ACM.
Ninebell repaid the loan in March 2018. ACM purchased materials from Ninebell amounting to
$2,483 and $1,865 during the three months ended June 30, 2019 and
2018, and $4,803 and $2,835 during the six months ended June 30,
2019 and 2018, respectively. As of June 30, 2019 and December 31,
2018, accounts payable due to Ninebell were $2,131 and $1,477,
respectively, and prepaid expenses prepaid to Ninebell for material
purchases were $751 and $572, respectively.
ACM
purchased materials from Shengyi amounting to $192 during the three
and six months ended June 30, 2019. As of June 30, 2019, accounts
payable due to Shengyi was $189.
In 2007
ACM Shanghai entered into an operating lease agreement with
Shanghai Zhangjiang Group Co., Ltd. (“Zhangjiang
Group”) to lease manufacturing and office space located in
Shanghai, China. An affiliate of Zhangjiang Group holds 787,098
shares of Class A common stock that it acquired in September 2017
for $5,903. Pursuant to the lease agreement, Zhangjiang Group
provided $771 to ACM Shanghai for leasehold improvements. In
September 2016 the lease agreement was amended to modify payment
terms and extend the lease through December 31, 2017. From January
1 to April 25, 2018, ACM Shanghai leased the property on a
month-to-month basis. On April 26, 2018, ACM Shanghai entered into
a renewed lease with Zhangjiang Group for the period from January
1, 2018 through December 31, 2022. Under the lease, ACM Shanghai
pays a monthly rental fee of RMB 366 (equivalent to $55). The
required security deposit was RMB 1,077 (equivalent to $163).
The Company incurred leasing expenses
under the lease agreement of $150 and $147 during the three months
ended June 30, 2019 and 2018, respectively, and $300 and $319
during the six months ended June 30, 2019 and 2018, respectively.
As of June 30, 2019 and December 31, 2018, payables to Zhangjiang
Group for lease expenses and leasehold improvements recorded as
other payables and accrued expenses amounted to $52 and $53,
respectively (note 7).
On
December 9, 2016, Shengxin (Shanghai) Management Consulting Limited
Partnership (“SMC”), a related party (note 11),
delivered RMB 20,124 (approximately $2,981 as of the close of
business on such date) in cash (the “SMC Investment”)
to ACM Shanghai for potential investment pursuant to terms to be
subsequently negotiated. SMC is a limited partnership incorporated
in the PRC, whose partners consist of employees of ACM Shanghai. On
March 14, 2017, ACM, ACM Shanghai and SMC entered into a securities
purchase agreement (the “SMC Agreement”) pursuant to
which, in exchange for the SMC Investment, ACM issued to SMC a
warrant (the “SMC Warrant”) exercisable, for cash or on
a cashless basis, to purchase, at any time on or before May 17,
2023, all, but not less than all, of 397,502 shares of Class A
common stock at a price of $7.50 per share, for a total exercise
price of $2,981. On March 30, 2018, SMC exercised the SMC Warrant
in full and purchased 397,502 shares of Class A common stock (note
12).
NOTE 12 – WARRANT LIABILITY
On
December 9, 2016, ACM Shanghai received the SMC Investment from SMC
for potential investment pursuant to terms to be subsequently
negotiated, and on March 14, 2017, ACM, ACM Shanghai and SMC
entered into the SMC Agreement pursuant to which, in exchange for
the SMC Investment, ACM issued the SMC Warrant to SMC (note
11).
The SMC
Warrant, while outstanding as of December 31, 2017, was classified
as a liability as it was conditionally puttable in accordance with
FASB ASC 480, Distinguishing
Liabilities from Equity. The fair value of the SMC Warrant
was adjusted for changes in fair value at each reporting period,
but could not be lower than the proceeds of the SMC Investment. The
corresponding non-cash gain or loss of the changes in fair value
was recorded in earnings. The Black-Scholes valuation model was
used to value the SMC Warrant.
On
March 30, 2018, ACM entered into a warrant exercise agreement with
ACM Shanghai and SMC pursuant to which SMC exercised the SMC
Warrant in full by issuing to ACM a senior secured promissory note
in the principal amount of $3,000. ACM then transferred such note
to ACM Shanghai in exchange for an intercompany promissory note of
ACM Shanghai in the principal amount of $3,000. Each of the two
notes bears interest at a rate of 3.01% per annum and matures on
August 17, 2023. As security for its performance of its obligations
under its note, SMC granted to ACM Shanghai a security interest in
the 397,502 shares of Class A common stock issued to SMC upon its
exercise of the SMC Warrant. Upon the issuance of 397,502 shares of
Class A common stock to SMC, the senior secured promissory note
issued to AMC by SMC was offset against the SMC
Investment.
16
ACM RESEARCH, INC.
Notes to Condensed Consolidated
Financial Statements (unaudited)
(in thousands, except share and per share data)
NOTE 13 – COMMON STOCK
ACM is
authorized to issue 50,000,000 shares of Class A common stock and
2,409,738 shares of Class B common stock, each with a par value of
$0.0001. Each share of Class A common stock is entitled to one
vote, and each share of Class B common stock is entitled to twenty
votes and is convertible at any time into one share of Class A
common stock. Shares of Class A common stock and Class B common
stock are treated equally, identically and ratably with respect to
any dividends declared by the Board of Directors unless the Board
of Directors declares different dividends to the Class A common
stock and Class B common stock by getting approval from a majority
of common stockholders.
On
March 30, 2018, SMC exercised the SMC Warrant in full (note 12) to
purchase 397,502 shares of Class A common stock.
During
the six months ended June 30, 2019, the Company issued 104,627
shares of Class A common stock upon option exercises by employees
and non-employees and an additional 15,000 shares of Class A common
stock upon conversion of an equal number of shares of Class B
common stock.
There
were issued and outstanding 14,229,942 shares of Class A common
stock and 1,883,423 shares of Class B common stock at June 30, 2019
and 14,110,315 shares of Class A common stock and 1,898,423 shares
of Class B common stock at December 31, 2018.
NOTE 14– STOCK-BASED COMPENSATION
ACM’s
stock-based compensation awards consisting of employee and
non-employee awards were issued under the 1998 Stock Option Plan
and 2016 Omnibus Incentive Plan and as standalone
options.
Employee Awards
The
following table summarizes the Company’s employee share
option activities during the six months ended June 30,
2019:
|
Number of Option Share
|
Weighted Average Grant Date Fair Value
|
Weighted Average Exercise Price
|
Weighed Average Remaining Contractual Term
|
Outstanding at December 31, 2018
|
2,503,405
|
0.91
|
4.09
|
7.30 years
|
Granted
|
295,000
|
6.50
|
16.81
|
|
Exercised
|
(48,098)
|
0.78
|
2.62
|
|
Expired
|
(628)
|
0.55
|
3.00
|
|
Forfeited
|
(4,085)
|
1.90
|
4.83
|
|
Outstanding at June
30, 2019
|
2,745,594
|
2.07
|
5.48
|
7.14 years
|
Vested and exercisable at June
30, 2019
|
1,608,352
|
|
|
|
During the three months ended June 30, 2019 and 2018, the Company
recognized employee stock-based compensation expense of $291 and
$170, respectively. During the six months ended June 30, 2019 and
2018, the Company recognized employee stock-based compensation
expense of $512 and $263, respectively. As of June 30, 2019 and
December 31, 2018, $3,662 and $2,424, respectively, of total
unrecognized employee stock-based compensation expense, net of
estimated forfeitures, related to stock-based awards were expected
to be recognized over a weighted-average period of 1.51 years and
1.62 years, respectively. Total recognized compensation cost may be
adjusted for future changes in estimated forfeitures.
Stock options to acquire 295,000 and 295,000 shares, respectively,
of Class A common stock were granted to employees during the three
and six months ended June 30, 2019.
The
following table summarizes the Company’s non-employee share
option activities during the six months ended June 30,
2019:
|
Number of Option Shares
|
Weighted Average Grant Date Fair Value
|
Weighted Average Exercise Price
|
Weighted Average Remaining Contractual Term
|
Outstanding at December 31, 2018
|
1,212,374
|
$0.78
|
$2.57
|
6.66 years
|
Granted
|
-
|
-
|
-
|
-
|
Exercised
|
(56,529)
|
0.33
|
0.81
|
-
|
Expired
|
-
|
-
|
-
|
-
|
Forfeited
|
-
|
-
|
-
|
-
|
Outstanding at June
30, 2019
|
1,155,845
|
$0.81
|
$2.66
|
6.62 years
|
Vested and exercisable at June
30, 2019
|
986,572
|
|
|
|
17
ACM RESEARCH, INC.
Notes to Condensed Consolidated
Financial Statements (unaudited)
(in thousands, except share and per share data)
The
Company adopted ASU 2018-07 on January 1, 2019, and the stock-based
compensation expense for grants before the adoption of ASU 2018-07
is based on the grant date fair value as of December 31, 2018,
which was the last business day before the Company adopted ASU
2018-07, for all nonemployee awards that have not vested as of
December 31, 2018. The cumulative-effect adjustment to retained
earnings as of January 1, 2019 was immaterial to the financial
statements as a whole. Accordingly, the Company did not record this
adjustment as of January 1, 2019. Furthermore, for future awards,
compensation expense is based on the market value of the shares at
the grant date.
During the three months
ended June 30, 2019 and 2018, the Company recognized
stock-based compensation expense of $327 and $14, respectively, related to
share option vesting. During the six months
ended June 30, 2019 and 2018, the Company recognized
stock-based compensation expense of $850 and $2,097, respectively, related to
share option vesting. As of June 30, 2019 and
December 31, 2018, $863 and $1,713, respectively, of total
unrecognized non-employee stock-based compensation expense, net of
estimated forfeitures, related to stock-based awards were expected
to be recognized over a weighted-average period of 0.64 years and
1.31 years, respectively. Total recognized compensation cost may be
adjusted for future changes in estimated
forfeitures.
NOTE 15 – INCOME TAXES
Income
taxes are accounted for under the asset and liability method.
Deferred tax assets and liabilities are recognized for the future
tax consequences attributable to differences between the financial
statement carrying amounts of existing assets and liabilities and
their respective tax bases and operating loss and tax credit
carry-forwards. Deferred tax assets and liabilities are measured
using enacted tax rates expected to apply to taxable income in the
years in which those temporary differences are expected to be
recovered or settled. The effect of a change in tax rates on
deferred tax assets and liabilities is recognized in income in the
period during which such rates are enacted.
The
Company considers all available evidence to determine whether it is
more likely than not that some portion or all of the deferred tax
assets will be realized. The ultimate realization of deferred tax
assets is dependent upon the generation of future taxable income
during the periods in which those temporary differences become
realizable. Management considers the scheduled reversal of deferred
tax liabilities (including the impact of available carryback and
carry-forward periods), and projected taxable income in assessing
the realizability of deferred tax assets. In making such judgments,
significant weight is given to evidence that can be objectively
verified. Based on all available evidence, in particular the
Company’s three-year historical cumulative losses, recent
operating results and U.S. pre-tax loss for the six months ended
June 30, 2019, the Company recorded a valuation allowance against
its U.S. net deferred tax assets. In order to fully realize the
U.S. deferred tax assets, the Company will need to generate
sufficient taxable income in future periods before the expiration
of the deferred tax assets governed by the tax code.
In
each period since inception, the Company has recorded a valuation
allowance for the full amount of net deferred tax assets in the
United States, as the realization of deferred tax assets is
uncertain. ACM Shanghai has shown a three-year historical
cumulative profit and has projections of future income. As a
result, the Company maintained a partial consolidated valuation
allowance for the three and six months ended June 30, 2019 and
December 31, 2018.
The
Company accounts for uncertain tax positions in accordance with the
authoritative guidance on income taxes under which the Company may
only recognize or continue to recognize tax positions that meet a
"more likely than not" threshold. The Company recognizes accrued
interest and penalties related to unrecognized tax benefits as a
component of the provision for income taxes.
The
Company’s effective tax rate differs from statutory rates of
21% for U.S. federal income tax purposes and 15% to 25% for Chinese
income tax purposes due to the effects of the valuation allowance
and certain permanent differences from book-tax differences. As a
result, the Company recorded income tax expense of $876 and $164
during the three months ended June 30, 2019 and 2018, respectively,
and $995 and $186 during the six months ended June 30, 2019 and
2018, respectively.
As of
June 30, 2019, the Company's total unrecognized tax benefits were
approximately $44, which would not affect the effective tax rate if
recognized. The Company will recognize interest and penalties, when
they occur, related to uncertain tax provisions as a component of
tax expense. No interest or penalties were recognized for the six
months ended June 30, 2019.
The
Company files income tax returns in the United States, and state
and foreign jurisdictions. The federal, state and foreign income
tax returns are under the statute of limitations subject to tax
examinations for the tax years ended December 31, 1999 through
December 31, 2017. This is due to the Company’s tax attribute
carry-forwards, the tax years in which the attribute was generated
may still be adjusted upon examination by the U.S. Internal Revenue
Service, state or foreign tax authorities to the extent utilized in
a future period.
18
ACM RESEARCH, INC.
Notes to Condensed Consolidated
Financial Statements (unaudited)
(in thousands, except share and per share data)
The Tax
Cuts and Jobs Act (the "Tax Act"), enacted on December 22, 2017,
introduced significant changes to U.S. income tax law. Effective
January 1, 2018, the Tax Act reduced the U.S. statutory tax rate
from 35% to 21% and created new taxes on certain foreign-sourced
earnings and certain intercompany payments. Due to the timing of
the enactment and the complexity involved in applying the
provisions of the Tax Act, the Company made reasonable estimates of
the effects and recorded provisional amounts in its financial
statements as of December 31, 2017. There were no adjustments made
in the six months ended June 30, 2019. The accounting for the tax
effects of the Tax Act was completed in 2018.
NOTE 16 – COMMITMENTS AND CONTINGENCIES
The
Company leases offices under non-cancelable operating lease
agreements. See note 12 for future minimum lease payments under
non-cancelable operating lease agreements with initial terms of one
year or more.
As of
June 30, 2019, the Company did not have any capital
commitments.
From
time to time the Company is subject to legal proceedings, including
claims in the ordinary course of business and claims with respect
to patent infringements. As of June 30, 2019, the Company did not
have any legal proceedings.
NOTE 17 – SUBSEQUENT EVENTS
In
connection with the Listing and the IPO, in July 2019, ACM Shanghai
submitted the required filings for approval of its capital increase
with the local agency of the PRC Ministry of Commerce (see note 1).
Once ACM Shanghai has received payment of the funding from all
committed investors, ACM Shanghai is to process additional PRC
governmental registrations for the capital increase with the local
branch of the PRC State Administration for Market Regulation. Upon
successful completion of those registrations, the investors will be
issued additional equity, representing 4.2% of the outstanding ACM
Shanghai shares.
19
Item 2. Management’s Discussion and
Analysis of Financial Condition and Results of
Operations
You should read the following discussion of our financial condition
and results of operations together with our condensed consolidated
financial statements and the related notes and other financial
information included elsewhere in this report and our Annual Report
on Form 10-K for the fiscal year ended December 31, 2018, or our
Annual Report. The following discussion contains forward-looking
statements that reflect our plans, estimates, and beliefs. Our
actual results could differ materially from those discussed in the
forward-looking statements. Factors that could cause or contribute
to these differences include those discussed below and elsewhere in
this report, particularly in the section titled “Item 1A.
Risk Factors” in Part II below.
Overview
We
supply advanced, innovative capital equipment developed for the
global semiconductor industry. Fabricators of advanced integrated
circuits, or chips, can use our single-wafer wet-cleaning tools in
numerous steps to improve product yield, even at increasingly
advanced process nodes. We have designed these tools for use in
fabricating foundry, logic and memory chips, including dynamic
random-access memory (or DRAM) and 3D NAND-flash memory chips. We
also develop, manufacture and sell a range of advanced packaging
tools to wafer assembly and packaging customers.
Selling
prices for our single-wafer wet-cleaning tools range from $2
million to more than $5 million. Our customers for single-wafer
wet-cleaning tools have included Semiconductor Manufacturing
International Corporation, Shanghai Huali Microelectronics
Corporation, SK Hynix Inc. and Yangtze Memory Technologies Co.,
Ltd. We recognized revenue from sales of single-wafer wet cleaning
equipment totaling $41.7 million, or 84% of total revenue, for the
first six months of 2019 compared to $28.7 million, or 94% of total
revenue, for the first six months of 2018.
We
focus our selling efforts on establishing a referenceable base of
leading foundry, logic and memory chip makers, whose use of our
products can influence decisions by other manufacturers. We believe
this customer base will help us penetrate the mature chip
manufacturing markets and build credibility with additional
industry leaders. Using a “demo-to-sales” process, we
have placed evaluation equipment, or “first tools,”
with a number of selected customers. Since 2009 we have delivered
more than 65 single-wafer wet cleaning tools, more than 55 of which
have been accepted by customers and thereby generated revenue to us
and the balance of which are awaiting customer acceptance should
contractual conditions be met.
Since
our formation in 1998, we have focused on building a strategic
portfolio of intellectual property to support and protect our key
innovations. Our wet-cleaning equipment has been developed using
our key proprietary technologies:
●
Space Alternated Phase Shift, or SAPS,
technology for flat and patterned wafer surfaces, which employs
alternating phases of megasonic waves to deliver megasonic energy
in a highly uniform manner on a microscopic level;
●
Timely Energized Bubble Oscillation, or
TEBO, technology for patterned wafer surfaces at advanced process
nodes, which provides effective, damage-free cleaning for 2D and 3D
patterned wafers with fine feature sizes; and
●
Tahoe technology for cost and
environmental savings, which delivers high cleaning performance
using significantly less sulfuric acid and hydrogen peroxide than
is typically consumed by conventional high-temperature single-wafer
cleaning tools.
We have
been issued more than 220 patents in the United States, the
People’s Republic of China or PRC, Japan, Korea, Singapore
and Taiwan.
We
conduct substantially all of our product development,
manufacturing, support and services in the PRC. All of our tools
are built to order at our manufacturing facilities in Shanghai,
which encompass 86,000 square feet of floor space for production
capacity. Our experience has shown that chip manufacturers in the
PRC and throughout Asia demand equipment meeting their specific
technical requirements and prefer building relationships with local
suppliers. We will continue to seek to leverage our local presence
to address the growing market for semiconductor manufacturing
equipment in the region by working closely with regional chip
manufacturers to understand their specific requirements, encourage
them to adopt our SAPS, TEBO and Tahoe technologies, and enable us
to design innovative products and solutions to address their
needs.
Corporate Background
ACM
Research was incorporated in California in 1998 and redomesticated
in Delaware in 2016. We perform strategic planning, marketing, and
financial activities at our global corporate headquarters in
Fremont, California.
Initially we
focused on developing tools for chip manufacturing process steps
involving the integration of ultra-low-K materials and copper. In
the early 2000s we sold tools based on stress-free copper polishing
technology.
20
To help
us establish and build relationships with chip manufacturers in the
PRC, in 2006 we moved our operational center to Shanghai and began
to conduct our business through our subsidiary ACM Shanghai. In
2007 we began to focus our development efforts on single-wafer
wet-cleaning solutions for the front-end chip fabrication
process.
In 2009
we introduced SAPS megasonic technology, which can be applied in
wet wafer cleaning at numerous steps during the chip fabrication
process. In 2016 we introduced TEBO technology, which can be
applied at numerous steps during the fabrication of small node
conventional two-dimensional and three-dimensional patterned
wafers.
In 2011
ACM Shanghai formed a wholly owned subsidiary in the PRC, ACM
Research (Wuxi), Inc., to manage sales and service operations. In
June 2017 we formed a wholly owned subsidiary in Hong Kong,
CleanChip Technologies Limited, to act on our behalf in Asian
markets outside the PRC by, for example, serving as a trading
partner between ACM Shanghai and its customers, procuring raw
materials and components, performing sales and marketing
activities, and making strategic investments.
In
December 2017 we formed a wholly owned subsidiary in the Republic
of Korea, ACM Research Korea CO., LTD., to serve our customers
based in the Republic of Korea and perform sales, marketing, and
research and development activities. We currently conduct the
majority of our product development, support and services, and
substantially all of our manufacturing at ACM Shanghai. Our
Shanghai operations position us to be near many of our current and
potential new customers in the PR (including Taiwan), Korea and
throughout Asia, providing convenient access and reduced shipping
and manufacturing costs.
In
August 2018 we introduced the Ultra-C Tahoe wafer cleaning tool,
which delivers high cleaning performance with significantly less
sulfuric acid than typically consumed by conventional high
temperature single-wafer cleaning tools.
In
September 2018 we announced the opening of a second factory in the
Pudong region of Shanghai. The new facility has a total of 50,000
square feet of available floor space for production capacity. This
is in addition to our first factory in the Pudong Region of
Shanghai, which has a total of 36,000 square feet of available
floor space.
In
March 2019, we introduced (a) the Ultra ECP AP, or Advanced Wafer
Level Packaging tool, a back-end assembly tool used for bumping, or
applying copper, tin and nickel to wafers at the die-level prior to
packaging, and (b) the Ultra ECP MAP or Multi Anode Plating tool, a
front-end process tool that utilizes our proprietary technology to
deliver world-class electrochemical copper planting for copper
interconnect applications.
Proposed Listing of ACM Shanghai Shares on STAR Market
For purposes of the following description, RMB amounts have been
translated into U.S. dollars solely for the convenience of the
reader. The translations have been made at the conversion rate of
RMB 6.8937 to U.S. $1.00 effective as of June 12, 2019.
See“Item 1A. Risk Factors” in Part II below for a
discussion of some of the risks and concerns that may arise as a
result of the proposed listing of ACM Shanghai shares and related
initial public offering of ACM Shanghai shares.
On June
17, 2019 we announced our plans to complete, over the next three
years:
●
a listing, which we
refer to as the Listing, of shares of ACM Shanghai on the Shanghai
Stock Exchange’s new Sci-Tech innovAtion boaRd, known as the
STAR Market; and
●
a concurrent
initial public offering, which we refer to as the STAR IPO, of ACM
Shanghai shares in the PRC.
To
qualify for the Listing, ACM Shanghai must have multiple
independent shareholders in the PRC. As an initial step in
qualifying for the Listing, on June 12, 2019 ACM Shanghai entered
into agreements with seven investors pursuant to which those
investors agreed to pay a purchase price totaling
RMB 187.9 million ($27.3 million) to ACM Shanghai
for shares representing 4.2% of the then-outstanding ACM Shanghai
shares. Pursuant to these agreements, in July 2019, ACM Shanghai
made the required filings for the capital increase with the local
agency of the PRC Ministry of Commerce, and the investors became
obligated to fund their purchases. As of the filing date for this
report:
●
Four private equity
funds and other entities based in the PRC have paid to ACM Shanghai
a total of RMB 141.8 million ($20.6 million) to be applied to
purchase 3.1% of ACM Shanghai’s shares at a purchase price
based on a pre-investment enterprise valuation of ACM Shanghai of
RMB 4.65 billion ($674.5 million).
●
Two entities owned
by certain employees of ACM Shanghai have paid to ACM Shanghai a
total of RMB 26.1 million ($3.8 million) to purchase 0.7% of ACM
Shanghai’s shares at a purchase price based on a
pre-investment enterprise valuation of ACM Shanghai of RMB 3.72
billion ($539.6 million), a discount of 20% from the purchase price
paid by the other investors.
●
A private equity
fund based in Hong Kong has agreed to pay a total of
RMB 20.0 million ($2.9 million) to purchase 0.4% of ACM
Shanghai’s shares at a purchase price based on a
pre-investment enterprise valuation of ACM Shanghai of RMB 4.65
billion ($674.5 million). We expect this investor will, consistent
with contractual obligations, fund their investment by September
2019, but ACM Shanghai’s receipt of those funds is not
necessary for ACM Shanghai to satisfy STAR Market listing
requirements.
21
Once it
has received payment of the purchase prices, ACM Shanghai is to
process necessary PRC governmental registrations for the capital
increase with the local branch of the PRC State Administration for
Market Regulation. Upon completion of those registrations, the
investors will be regarded as the owners of their subscribed
shares.
ACM
Shanghai and the investors have agreed to use their respective best
efforts to facilitate the completion, within three years from the
date on which the ACM Shanghai shares are issued to the investors,
of the Listing and the STAR IPO, with the STAR IPO to be completed
at a pre-offering valuation of not less than RMB 5.15 billion
($747.1 million). If, by the end of such three-year period,
the Listing and the STAR IPO have not been completed and the China
Securities Regulatory Commission has not otherwise approved the
registration of ACM Shanghai’s Listing application, each
investor will have the right to require that ACM Shanghai
repurchase, and ACM Shanghai will have the right to purchase, the
investor’s ACM Shanghai shares for a price equal to the
initial purchase price paid by the investor, without
interest.
We have
determined, voluntarily and not pursuant to any contractual or
legal obligation, that ACM Shanghai will deposit, and hold in
reserve, the proceeds from the share sales in segregated cash and
cash-equivalent accounts pending either (a) completion of the
Listing and the STAR IPO or (b) application to repurchase the
shares from the investors.
We may
determine to enter into additional agreements in the year ending
December 31, 2019 pursuant to which certain existing ACM Research
stockholders and other investors could purchase additional shares
of ACM Shanghai for an aggregate purchase price of approximately
$42 million. We expect that, if we were to enter any such
agreements, the purchase price and other terms of those agreements
would be substantially similar to those under the agreements
entered into with the investors other than the employee
entities.
PRC
Government Research and Development Funding
ACM
Shanghai has received four grants from local and central
governmental authorities in the PRC. The first grant, which was
awarded in 2008, relates to the development and commercialization
of 65nm to 45nm stress-free polishing technology. The second grant
was awarded in 2009 to fund interest expense on short-term
borrowings. The third grant was made in 2014 and relates to the
development of electro copper-plating technology. The fourth grant
was made in June 2018 and related to development of
polytetrafluoroethylene. PRC governmental authorities provide the
majority of the funding, although ACM Shanghai is also required to
invest certain amounts in the projects.
The PRC
governmental grants contain certain operating conditions, and we
are required to go through a government due diligence process once
the project is complete. The grants therefore are recorded as
long-term liabilities upon receipt, although we are not required to
return any funds we receive. Grant amounts are recognized in our
statements of operations and comprehensive income as
follows:
●
Government
subsidies relating to current expenses are reflected as reductions
of those expenses in the periods in which they are reported. Those
reductions totaled $2.0 million in the first six months of 2019, as
compared to $0.4 million in the first six months of
2018.
●
Government grants
used to acquire depreciable assets are transferred from long-term
liabilities to property, plant and equipment when the assets are
acquired and then the recorded amounts of the assets are credited
to other income over the useful lives of the assets. Related
government subsidies recognized as other income totaled less than
$100,000 in the first six months of 2019 and 2018.
How We Evaluate Our Operations
We
present information below with respect to four measures of
financial performance:
●
We define
“shipments” of tools to include (a)a
“repeat” delivery to a customer of a type of tool that
the customer has previously accepted, for which we recognize
revenue upon delivery, and (b)a “first-time” delivery
of a tool to a customer on an approval basis, for which we may
recognize revenue in the future if contractual conditions are met
and customer acceptance is received.
●
We define
“adjusted EBITDA” as our net income excluding interest
expense (net), income tax benefit (expense), depreciation and
amortization, and stock-based compensation. We define adjusted
EBITDA to also exclude restructuring costs, although we have not
incurred any such costs to date.
●
We define
“free cash flow” as net cash provided by operating
activities less purchases of property and equipment (net of
proceeds from disposals) and of intangible assets.
●
We define
“adjusted operating income” as our income from
operations excluding stock-based compensation.
22
These
financial measures are not based on any standardized methodologies
prescribed by accounting principles generally accepted in the
United States, or GAAP, and are not necessarily comparable to
similarly titled measures presented by other
companies.
We have
presented shipments, adjusted EBITDA, free cash flow and adjusted
operating income because they are key measures used by our
management and board of directors to understand and evaluate our
operating performance, to establish budgets and to develop
operational goals for managing our business. We believe that these
financial measures help identify underlying trends in our business
that could otherwise be masked by the effect of the expenses that
we exclude. In particular, we believe that the exclusion of the
expenses eliminated in calculating adjusted EBITDA and adjusted
operating income can provide useful measures for period-to-period
comparisons of our core operating performance and that the
exclusion of property and equipment purchases from operating cash
flow can provide a usual means to gauge our capability to generate
cash. Accordingly, we believe that these financial measures provide
useful information to investors and others in understanding and
evaluating our operating results, enhancing the overall
understanding of our past performance and future prospects, and
allowing for greater transparency with respect to key financial
metrics used by our management in its financial and operational
decision-making.
Shipments, adjusted
EBITDA, free cash flow and adjusted operating income are not
prepared in accordance with GAAP, and should not be considered in
isolation of, or as an alternative to, measures prepared in
accordance with GAAP.
Shipments
Shipments consist
of two components:
●
a shipment to a
customer of a type of tool that the customer has
previously-accepted, for which we recognize revenue when the tool
is delivered; and
●
a shipment to a
customer of a type of tool that the customer is receiving and
evaluating for the first time, in each case a “first
tool,” for which we may recognize revenue at a later date,
subject to the customer’s acceptance of the tool upon the
tool’s satisfaction of applicable contractual
requirements.
“First
tool” shipments can be made to either an existing customer
that not previously accepted that specific type of tool in the past
─ for example, a delivery of SAPS V tool to a customer that
previously had received only SAPS II tools ─ or to a new
customer that has never purchased any tool from us.
Shipments in the
three months ended June 30, 2019 totaled $33 million, as compared
to $21 million in the three months ended June 30, 2018 and $14
million in the three months ended March 31, 2019. Shipments in the
six months ending June 30, 2019 totaled $47 million, as compared to
$31 million in the six months ended June 30, 2018.
The
dollar amount attributed to a “first tool” shipment is
equal to the consideration we expect to receive if any and all
contractual requirements are satisfied and the customer accepts the
tool. There are a number of limitations related to the use of
shipments in evaluating our business, including that customers have
significant discretion in determining whether to accept our tools
and their decision not to accept delivered tools is likely to
result in our inability to recognize revenue from the delivered
tools.
Adjusted EBITDA
There
are a number of limitations related to the use of adjusted EBITDA
rather than net income, which is the nearest GAAP equivalent. Some
of these limitations are:
●
adjusted EBITDA
excludes depreciation and amortization and, although these are
non-cash expenses, the assets being depreciated or amortized may
have to be replaced in the future;
●
we exclude
stock-based compensation expense from adjusted EBITDA and adjusted
operating income, although (a) it has been, and will continue to be
for the foreseeable future, a significant recurring expense for our
business and an important part of our compensation strategy and (b)
if we did not pay out a portion of our compensation in the form of
stock-based compensation, the cash salary expense included in
operating expenses would be higher, which would affect our cash
position;
●
the expenses and
other items that we exclude in our calculation of adjusted EBITDA
may differ from the expenses and other items, if any, that other
companies may exclude from adjusted EBITDA when they report their
operating results;
●
adjusted EBITDA
does not reflect changes in, or cash requirements for, working
capital needs;
●
adjusted EBITDA
does not reflect interest expense, or the requirements necessary to
service interest or principal payments on debt;
●
adjusted EBITDA
does not reflect income tax expense (benefit) or the cash
requirements to pay taxes;
●
adjusted EBITDA
does not reflect historical cash expenditures or future
requirements for capital expenditures or contractual
commitments;
●
although
depreciation and amortization charges are non-cash charges, the
assets being depreciated and amortized will often have to be
replaced in the future, and adjusted EBITDA does not reflect any
cash requirements for such replacements; and
●
adjusted EBITDA
includes expense reductions and non-operating other income
attributable to PRC governmental grants, which may mask the effect
of underlying developments in net income, including trends in
current expenses and interest expense, and free cash flow includes
the PRC governmental grants, the amount and timing of which can be
difficult to predict and are outside our control.
23
The
following table reconciles net income, the most directly comparable
GAAP financial measure, to adjusted EBITDA:
|
Six Months Ended June
30,
|
|
|
2019
|
2018
|
|
(in
thousands)
|
|
Adjusted EBITDA Data:
|
|
|
Net
Income
|
$6,168
|
$435
|
Interest expense,
net
|
300
|
235
|
Income tax expense
|
995
|
186
|
Depreciation and
amortization
|
388
|
173
|
Stock based
compensation
|
1,362
|
2,360
|
Adjusted EBITDA
|
$9,213
|
$3,389
|
Adjusted EBITDA in
the six months ended June 30, 2019, increased by $5.8 million as
compared to the same period in 2018, due to an increase of $5.7
million in net income, an increase of $65,000 in interest expense,
an increase of $809,000 in income tax expense, and an increase of
$215,000 in depreciation and amortization, offset in part by a
decrease of $998,000 in stock-based compensation expense. We do not
exclude from adjusted EBITDA expense reductions and non-operating
other income attributable to PRC governmental grants because we
consider and incorporate the expected amounts and timing of those
grants in incurring expenses and capital expenditures. If we did
not receive the grants, our cash expenses therefore would be lower,
and our cash position would not be affected, to the extent we have
accurately anticipated the amounts of the grants. For additional
information regarding our PRC grants, please see “—Key
Components of Results of Operations—PRC Government Research
and Development Funding.”
Free Cash Flow
The
following table reconciles net cash provided by operating
activities, the most directly comparable GAAP financial measure, to
free cash flow:
|
Six Months Ended June
30,
|
|
|
2019
|
2018
|
|
(in
thousands)
|
|
Free Cash Flow Data:
|
|
|
Net cash used in operating
activities
|
$(4,607)
|
$(4,118)
|
Purchase of property and
equipment
|
(325)
|
(882)
|
Purchase of intangible
assets
|
(71)
|
(157)
|
Free cash flow
|
$(5,003)
|
$(5,157)
|
Free
cash flow in the six months ended June 30, 2019, improved by
$154,000 as compared with the same period in 2018, due to an
increase of $489,000 of cash used in operating activities that was
offset by a decrease of $557,000 in purchase of property and
equipment. Consistent with our methodology for calculating adjusted
EBITDA, we do not adjust free cash flow for the effects of PRC
government subsidies, because we take those subsidies into account
in incurring expenses and capital expenditures.
Adjusted Operating Income
Adjusted operating
income excludes stock-based compensation from income from
operations. Although stock-based compensation is an important
aspect of the compensation of our employees and executives,
determining the fair value of certain of the stock-based
instruments we utilize involves a high degree of judgment and
estimation and the expense recorded may bear little resemblance to
the actual value realized upon the vesting or future exercise of
the related stock-based awards. Furthermore, unlike cash
compensation, the value of stock options, which is an element of
our ongoing stock-based compensation expense, is determined using a
complex formula that incorporates factors, such as market
volatility, that are beyond our control. Management believes it is
useful to exclude stock-based compensation in order to better
understand the long-term performance of our core business and to
facilitate comparison of our results to those of peer companies.
The use of non-GAAP financial measures excluding stock-based
compensation has limitations, however. If we did not pay out a
portion of our compensation in the form of stock-based
compensation, the cash salary expense included in operating
expenses would be higher and our cash holdings would be less. The
following tables reflect the exclusion of stock-based compensation,
or SBC, from line items comprising income from
operations:
Adjusted operating
income for the three months ended on June 30, 2019, as compared
with the same period in 2018, reflected a $434,000 increase in
stock-based compensation expense.
24
|
Three Months Ended June 30,
|
|||||
|
2019
|
2018
|
||||
|
Actual (GAAP)
|
SBC
|
Adjusted (Non-GAAP)
|
Actual (GAAP)
|
SBC
|
Adjusted (Non-GAAP)
|
|
(in
thousands)
|
|||||
Revenue
|
$29,010
|
$-
|
$29,010
|
$20,873
|
$-
|
$20,873
|
Cost of revenue
|
(15,879)
|
(29)
|
(15,850)
|
(12,149)
|
(11)
|
(12,138)
|
Gross profit
|
13,131
|
(29)
|
13,160
|
8,724
|
(11)
|
8,735
|
Operating expenses:
|
|
|
|
|
|
|
Sales and marketing
|
(2,924)
|
(46)
|
(2,878)
|
(2,682)
|
(39)
|
(2,643)
|
Research and development
|
(3,341)
|
(94)
|
(3,247)
|
(2,419)
|
(40)
|
(2,379)
|
General and administrative
|
(2,205)
|
(449)
|
(1,756)
|
(1,292)
|
(94)
|
(1,198)
|
Income (loss) from operations
|
$4,661
|
$(618)
|
$5,279
|
$2,331
|
$(184)
|
$2,515
|
Adjusted operating
income for the six months ended on June 30, 2019, as compared with
the same period in 2018, reflected a $998,000 decrease in
stock-based compensation expense.
|
Six Months Ended
June 30,
|
|||||
|
2019
|
2018
|
||||
|
Actual
(GAAP)
|
SBC
|
Adjusted
(Non-GAAP)
|
Actual
(GAAP)
|
SBC
|
Adjusted
(Non-GAAP)
|
|
(in
thousands)
|
|||||
Revenue
|
$49,489
|
$-
|
$49,489
|
$30,616
|
$-
|
$30,616
|
Cost of revenue
|
(27,532)
|
(59)
|
(27,473)
|
(16,770)
|
(19)
|
(16,751)
|
Gross profit
|
21,957
|
(59)
|
22,016
|
13,846
|
(19)
|
13,865
|
Operating expenses:
|
|
|
|
|
|
|
Sales and marketing
|
(4,793)
|
(80)
|
(4,713)
|
(4,537)
|
(73)
|
(4,464)
|
Research and development
|
(6,106)
|
(180)
|
(5,926)
|
(3,960)
|
(67)
|
(3,893)
|
General and administrative
|
(4,146)
|
(1,043)
|
(3,103)
|
(4,922)
|
(2,201)
|
(2,721)
|
Income (loss) from operations
|
$6,912
|
$(1,362)
|
$8,274
|
$427
|
$(2,360)
|
$2,787
|
Critical Accounting Policies and Significant Judgments and
Estimates
There
were no significant changes in our critical accounting policies or
significant judgments or estimates during the six months ended June
30, 2019 to augment the critical accounting estimates disclosed
under the heading “Management’s Discussion and Analysis
of Financial Condition and Results of Operations” in our
Annual Report, other than those described in the notes to the
condensed consolidated financial statements included in this
report, including the adoption of the Financial Accounting
Standards Board’s Accounting Standards Update 2016-02,
Leases (Topic 842)
effective January 1, 2019. As a result of our adoption of the new
lease standard, we re-assessed the estimates, assumptions, and
judgments that are most critical in our recognition of lease and
have revised our lease critical accounting policy. For information
regarding the impact of recently adopted accounting standards,
refer to note 2 to the condensed financial statements included in
this report.
25
Recent Accounting Pronouncements
A
discussion of recent accounting pronouncements is included in our
Annual Report and is updated in note 2 to the condensed
consolidated financial statements included in this
report.
Results of Operations
The
following table sets forth our results of operations for the
periods presented, as percentages of revenue.
|
Three Months
Ended June 30,
|
Six Months Ended
June 30,
|
||
|
2019
|
2018
|
2019
|
2018
|
Revenue
|
100.0%
|
100.0%
|
100.0%
|
100.0%
|
Cost of revenue
|
54.7
|
58.2
|
55.6
|
54.8
|
Gross margin
|
45.3
|
41.8
|
44.4
|
45.2
|
Operating expenses:
|
|
|
|
|
Sales and marketing
|
10.1
|
12.8
|
9.7
|
14.8
|
Research and development
|
11.5
|
11.6
|
12.3
|
12.9
|
General and administrative
|
7.6
|
6.2
|
8.4
|
16.1
|
Total operating expenses, net
|
29.2
|
30.6
|
30.4
|
43.8
|
Income from operations
|
16.1
|
11.2
|
14.0
|
1.4
|
Interest expense, net
|
(0.6)
|
(0.6)
|
(0.6)
|
(0.7)
|
Other
expense, net
|
1.9
|
5.1
|
0.6
|
1.0
|
Equity income in
net income of affiliates
|
0.5
|
0.6
|
0.5
|
0.4
|
Income before income taxes
|
17.9
|
16.3
|
14.5
|
2.1
|
Income tax expense
|
(3.0)
|
(0.8)
|
(2.0)
|
(0.6)
|
Net
income
|
14.9
|
15.5
|
12.5
|
1.5
|
Comparison of Three Months Ended June 30, 2019 and
2018
Revenue
|
Three Months
Ended June 30,
|
|
|
|
2019
|
2018
|
% Change 2019 v
2018
|
|
(in
thousands)
|
|
|
Revenue
|
$29,010
|
$20,873
|
39.0%
|
The
increase in revenue of $8.1 million in the three months ended June
30, 2019 as compared to the same period in 2018 reflected increases
in revenue of $9.7 million from single-wafer cleaning equipment. .
The revenue increase reflected an
increased number of tools shipped, coupled with higher selling
prices associated with the equipment sold and customer acceptances
from prior period shipments received and recognized as revenue
during the three month ended June 30, 2019.
Cost of Revenue and Gross Margin
|
Three Months
Ended June 30,
|
|
|
|
2019
|
2018
|
% Change 2019 v
2018
|
|
(in
thousands)
|
|
|
Cost of revenue
|
$15,879
|
$12,149
|
30.7%
|
Gross profit
|
$13,131
|
$8,724
|
50.5
|
Gross margin
|
45.26%
|
41.80%
|
3.5
|
26
Cost of
revenue increased $3.7 million and gross profit increased $4.4
million in the three months ended June 30, 2019, as compared to the
corresponding period in 2018, primarily due to increased sales
volume. Gross margin increased by 3.5% during the three months
ended June 30, 2019, from the comparable period in 2018. Gross
margin in the second quarter of 2019 reflected a favorable mix of
SAPS-V and SAPS-II tools.
Gross
margin may vary from period to period, primarily related to the
level of utilization and the timing and mix of purchase orders. We
expect gross margin to be between 40.0% and 45.0% for the
foreseeable future, with direct manufacturing costs approximating
50.0% to 55.0% of revenue and overhead costs totaling 5.0% of
revenue.
Operating Expenses
|
Three Months
Ended June 30,
|
|
|
|
2019
|
2018
|
% Change 2019 v
2018
|
|
(in
thousands)
|
|
|
Sales and marketing expense
|
$2,924
|
$2,682
|
9.0%
|
Research and development expense
|
3,341
|
2,419
|
38.1
|
General and administrative expense
|
2,205
|
1,292
|
70.7
|
Total operating expenses
|
$8,470
|
$6,393
|
32.5
|
Sales and marketing expense increased
by $242,000 in the three months ended June 30, 2019, as compared to
the corresponding period in 2018. Sales and marketing expense consists primarily
of:
●
compensation
of personnel associated with pre and aftersales support and other
sales and marketing activities, including stock-based
compensation;
●
sales
commissions paid to independent sales representatives;
●
fees
paid to sales consultants;
●
shipping
and handling costs for transportation of products to
customers;
●
cost
of trade shows;
●
travel
and entertainment; and
●
allocated
overhead for rent and utilities.
Research and development expense
increased by $922,000 in the three months ended June 30, 2019 as
compared to the corresponding period in 2018, principally as a
result of increases in testing fees and personnel costs. Research
and development expense represented 11.5% and 11.6% of our revenue
in the three months ended June 30, 2019 and 2018, respectively.
Without reduction by grant amounts
received from PRC governmental authorities (see “—Key
Components of Results of Operations—PRC Government Research
and Development Funding”), gross research and development
expense totaled $4.1 million, or 14.0% of revenue, in the three
months ended June 30, 2019 and $2.6 million, or 12.5% of revenue,
in the three months ended June 30, 2018. Research and development
expense relates to the development of new products and processes
and encompasses our research, development and customer support
activities. Research and development expense consists primarily
of:
●
compensation
of personnel associated with our research and development
activities, including stock based compensation;
●
costs
of components and other research and development
supplies;
●
travel
expense associated with customer support;
●
amortization
of costs of software used for research and development purposes;
and
●
allocated
overhead for rent and utilities.
General and administrative expense
increased by $913,000 in the three months ended June 30, 2019 as
compared to the corresponding period in 2018. General and
administrative expense consists primarily of:
●
compensation
of executive, accounting and finance, human resources, information
technology, and other administrative personnel, including
stock-based compensation;
●
professional
fees, including accounting and legal fees;
●
other
corporate expenses; and
●
allocated
overhead for rent and utilities.
We expect that, for the foreseeable future, general and
administrative expenses will increase in absolute dollars, as we
incur additional costs associated with growing our business and
operating as a public company
27
Other Income and Expenses
|
Three Months
Ended June 30,
|
|
|
|
2019
|
2018
|
% Change 2019 v
2018
|
|
(in
thousands)
|
|
|
Interest expense, net
|
$(170)
|
$(135)
|
25.9%
|
Other income, net
|
543
|
1,066
|
(49.1)
|
Interest expense
consists of interest incurred from outstanding short-term
borrowings. Interest expense increased by $35,000 in the three
months ended June 30, 2019 as compared to the three months ended
June 30, 2018, principally as a result of increased borrowings
under short-term bank loans. We earn interest income from
depositary accounts. Interest income was nominal in the three
months ended June 30, 2019 and 2018.
Non-operating
income (expense), net primarily reflects (a) gains or losses
recognized from the impact of exchange rates on our foreign
currency-denominated working-capital transactions and (b)
depreciation of assets acquired with government subsidies, as
described under “—Key Components of Results of
Operations—PRC Government Research and Development
Funding” above. Our non-operating income was $543,000 in the
three months ended June 30, 2019 due to gains and losses of the RMB
to US dollar exchange rate during the quarter, compared to
non-operating expense of $1.1 million in the three months ended
June 30, 2018 due to gains and losses of RMB-to-US dollar exchange
rate during the quarter.
Income Tax Expense
The
following presents components of income tax expense for the
indicated periods:
|
Three Months
Ended June 30,
|
|
|
2019
|
2018
|
|
(in
thousands)
|
|
Current:
|
|
|
U.S. federal
|
$-
|
$-
|
U.S. state
|
|
-
|
Foreign
|
(876)
|
-
|
Total
current income tax expense
|
(876)
|
-
|
Deferred:
|
|
|
U.S. federal
|
|
-
|
U.S. state
|
|
-
|
Foreign
|
|
(164)
|
Total
deferred income expense
|
-
|
(164)
|
Total
current income tax expense
|
$(876)
|
$(164)
|
On
December 22, 2017, the Tax Cuts and Jobs Act, or the Tax Act, was
enacted into law. The new legislation contains several key tax
provisions that affect us, including a one-time mandatory
transition tax on accumulated foreign earnings and a reduction of
the corporate income tax rate to 21% effective January 1, 2018. Due
to the timing of the enactment and the complexity involved in
applying the provisions of the Tax Act, we made reasonable
estimates of the effects and recorded provisional amounts in our
financial statements as of December 31, 2017. There were no
adjustments made in the three months ended June 30, 2019. The
accounting for the tax effects of the Tax Act was completed in
2018.
28
As we
collect and prepare necessary data, and interpret the Tax Act and
any additional guidance issued by the U.S. Treasury Department, the
Internal Revenue Service, and other standard-setting bodies, we may
make adjustments to the provisional amounts. Those adjustments may
materially affect our provision for income taxes and effective tax
rate in the period in which the adjustments are made. There were no
adjustments made in the first nine months of 2018.
Our
effective tax rate differs from statutory rates of 21% for U.S.
federal income tax purposes and 15% to 25% for Chinese income tax
purposes due to the effects of the valuation allowance and certain
permanent differences as it pertains to book-tax differences in the
value of client equity securities received for services. Our two
PRC subsidiaries, ACM Shanghai and ACM Wuxi, are liable for PRC
corporate income taxes at the rates of 15% and 25%, respectively.
Pursuant to the Corporate Income Tax Law of the PRC, our PRC
subsidiaries generally would be liable for PRC corporate income
taxes as a rate of 25%. According to Guoshuihan 2009 No. 203, an
entity certified as an “advanced and new technology
enterprise” is entitled to a preferential income tax rate of
15%. ACM Shanghai was certified as an “advanced and new
technology enterprise” in 2012 and again in 2016, with an
effective period of three years.
We file
income tax returns in the United States and state and foreign
jurisdictions. Those federal, state and foreign income tax returns
are under the statute of limitations subject to tax examinations
for 2009 through 2016. To the extent we have tax attribute
carryforwards, the tax years in which the attribute was generated
may still be adjusted upon examination by the Internal Revenue
Service or state or foreign tax authorities to the extent utilized
in a future period.
Comparison of Six Months Ended June 30, 2019 and 2018
Revenue
|
Six Months Ended June 30,
|
|
|
|
2019
|
2018
|
Y/Y % Change
|
|
(in thousands)
|
|
|
Revenue
|
$49,489
|
$30,616
|
61.6%
|
The
increase in revenue of $18.9 million in the three months ended June
30, 2019 as compared to the same period in 2018, was driven
primarily by a $13.0 million increase of revenue from single-wafer
cleaning tools. The revenue increase
reflected an increased number of tools shipped, coupled with higher
selling prices associated with the equipment sold and customer
acceptances from prior period shipments received and recognized as
revenue during the six-months ended June 30,
2019.
Cost of Revenue and Gross Margin
|
Six Months Ended June 30,
|
|
|
|
2019
|
2018
|
Y/Y % Change
|
|
(in
thousands)
|
|
|
Cost of revenue
|
$27,532
|
$16,770
|
64.2%
|
Gross profit
|
$21,957
|
$13,846
|
58.6
|
Gross margin
|
44.4%
|
45.2%
|
(86
bps)
|
Cost of
revenue increased $10.8 million and gross profit increased $8.1
million in the six months ended June 30, 2019, as compared to the
corresponding period in 2018, primarily due to increased sales
volume. Gross margin decreased by 86 basis points during the six
months ended June 30, 2019, from the comparable period in
2018.
29
Operating Expenses
|
Six Months Ended June 30,
|
|
|
|
2019
|
2018
|
Y/Y % Change
|
|
(in thousands)
|
|
|
Sales and marketing expense
|
$4,793
|
$4,537
|
5.6%
|
Research and development expense
|
6,106
|
3,960
|
54.2
|
General and administrative expense
|
4,146
|
4,922
|
(15.8)
|
Total operating expenses
|
$15,045
|
$13,419
|
12.1
|
Sales and marketing expense increased
by $256,000 in the six months ended June 30, 2019, as compared to
the corresponding period in 2018.
Research and development expense
increased by $2.1 million in the six months ended June 30, 2019 as
compared to the corresponding period in 2018, principally as a
result of increases in testing fees and personnel costs. Research
and development expense represented 12.3% and 12.9% of our revenue
in the six months ended June 30, 2019 and 2018, respectively.
Without reduction by grant amounts
received from PRC governmental authorities (see “—Key
Components of Results of Operations—PRC Government Research
and Development Funding”), gross research and development
expense totaled $8.1 million, or 16.4% of revenue, in the six
months ended June 30, 2019 and $4.4 million, or 14.2% of revenue,
in the six months ended June 30, 2018. Research and development
expense relates to the development of new products and processes
and encompasses our research, development and customer support
activities.
General and administrative expense
decreased by $776,000 in the six months ended June 30, 2019 as
compared to the corresponding period in 2018.
Other Income and Expenses
|
Six Months Ended June 30,
|
|
|
|
2019
|
2018
|
Y/Y % Change
|
|
(in thousands)
|
|
|
Interest expense, net
|
$(300)
|
$(235)
|
27.7%
|
Other income, net
|
282
|
311
|
(9.3)
|
Interest expense
increased by $65,000 in the six months ended June 30, 2019 as
compared to the three months ended June 30, 2018, principally as a
result of increased borrowings under short-term bank loans. We earn
interest income from depositary accounts. Interest income was
nominal in the six months ended June 30, 2019 and
2018.
Our
non-operating income was $282,000 in the six months ended June 30,
2019 due to gains and losses of the RMB to US dollar exchange rate
during the quarter, compared to non-operating income of $311,000 in
the six months ended June 30, 2018 due to gains and losses of
RMB-to-US dollar exchange rate during the quarter.
30
Income Tax Expense
The
following presents components of income tax expense for the
indicated periods:
|
Six Months Ended June 30,
|
|
|
2019
|
2018
|
|
(in thousands)
|
|
Current:
|
|
|
U.S.
federal
|
$-
|
$-
|
U.S.
state
|
-
|
-
|
Foreign
|
(995)
|
-
|
Total
current tax expense
|
(995)
|
-
|
Deferred:
|
|
|
U.S.
federal
|
-
|
-
|
U.S.
state
|
-
|
-
|
Foreign
|
|
(186)
|
Total
deferred tax expense
|
|
|
Total
income tax expense
|
(995)
|
(186)
|
There
were no adjustments with respect to the Tax Act made in the six
months ended June 30, 2019.
31
Liquidity and Capital Resources
During
the first six months of 2019 we funded our technology development
and operations principally through application of proceeds from the
initial public offering of Class A common stock and concurrent
private placements in November 2017 and, to a lesser extent, from
short-term borrowings by ACM Shanghai from local financial
institutions. During the six month period ended June 30, 2019, our
operations used cash flow of $4.6 million, and we received $1.5
million research and development grants from local and central PRC
governmental authorities.
We
believe our existing cash and cash equivalents, our cash flow from
operating activities, and short-term bank borrowings by ACM
Shanghai will be sufficient to meet our anticipated cash needs for
at least the next twelve months. We do not expect that our
anticipated cash needs for the next twelve months will require our
receipt of any PRC government subsidies. Our future working capital
needs will depend on many factors, including the rate of our
business and revenue growth, the payment schedules of our
customers, and the timing of investment in our research and
development as well as sales and marketing. To the extent our cash
and cash equivalents, cash flow from operating activities and
short-term bank borrowings are insufficient to fund our future
activities in accordance with our strategic plan, we may determine
to raise additional funds through public or private debt or equity
financings or additional bank credit arrangements. We also may need
to raise additional funds in the event we determine in the future
to effect one or more acquisitions of businesses, technologies and
products. If additional funding is necessary or desirable, we may
not be able to obtain bank credit arrangements or to affect an
equity or debt financing on terms acceptable to us or at
all.
As
described above under “—Overview—Proposed Listing
of ACM Shanghai Shares on STAR Market,” proceeds received
from investors to purchase shares of ACM Shanghai in the third
quarter of 2019 will be deposited and held in reserve in segregated
cash and cash-equivalent accounts pending either (a) completion of
the STAR Market listing and PRC initial public offering or (b)
application to repurchase the shares from the investors. As a
result, during that period those proceeds will not be available to
operate our business or for other corporate purposes.
Sources of Funds
Equity and
Equity-Related Securities. During the three months ended
June 30, 2019 we received proceeds of $172,000 from sales of common
stock pursuant to option exercises.
Indebtedness.
ACM Shanghai is a party to lines of credit with five banks, as
follows:
|
|
|
|
|
|
|
|
|
|
|
Lender
|
|
Agreement Date
|
|
Maturity Date
|
|
Annual
Interest Rate
|
|
Maximum Borrowing
Amount(1)
|
|
Amount Outstanding
at June 30, 2019
|
|
|
|
|
|
|
|
|
(in thousands)
|
||
Bank of China Pudong Branch
|
|
August 2018
|
|
August 2019
|
|
5.22%
|
|
RMB30,000
|
|
|
|
|
|
|
|
|
|
|
$4,365
|
|
-
|
Bank of Shanghai Pudong Branch
|
|
January 2019
|
|
January 2020
|
|
5.22%
|
|
RMB50,000
|
|
RMB24,500
|
|
|
|
|
|
|
|
|
$7,275
|
|
$3,565
|
Shanghai Rural Commercial Bank
|
|
February 2019
|
|
January 2020
|
|
5.66%
|
|
RMB20,000
|
|
RMB10,000
|
|
|
|
|
|
|
|
|
$2,910
|
|
$1,455
|
Bank of Communications
|
|
January 2019
|
|
January 2020 -
|
|
5.66%
|
|
RMB20,000
|
|
RMB20,000
|
|
|
|
|
February 2020
|
|
|
|
$2,911
|
|
$2,911
|
China Everbright Bank
|
|
February 2019
|
|
March 2020 -
|
|
4.94% -
|
|
RMB50,000
|
|
RMB49,352
|
|
|
|
|
June 2020
|
|
5.66%
|
|
$7,275
|
|
$7,179
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RMB170,000
|
|
RMB103,852
|
|
|
|
|
|
|
|
|
$24,736
|
|
15,110
|
(1) Converted
from RMB to dollars as of June 30, 2019.
All
of the amounts owing under the line of credit with Bank of China
Pudong Branch are secured by ACM Shanghai’s intellectual
property and guaranteed by Dr. David Wang, our Chair of the Board,
Chief Executive Officer and President. All of the amounts owing
under the lines of credit with Bank of Shanghai Pudong Branch are
guaranteed by Dr. Wang and Cleanchip Technologies Ltd. All of the
amounts owing under the line of credit with Shanghai Rural
Commercial Bank are secured by accounts receivable and guaranteed
by Dr. Wang. All of the amounts owing under the lines of credit
with China Everbright Bank are guaranteed by Dr. Wang.
32
Working
Capital. The
following table sets forth selected working capital
information:
|
June 30,
2019
|
|
(in thousands)
|
Cash and cash equivalents
|
$27,578
|
Accounts receivable, less allowance for doubtful amounts
|
31,393
|
Inventory
|
45,494
|
Working capital
|
$104,465
|
Our
cash and cash equivalents at June 30, 2019 were unrestricted and
held for working capital purposes. ACM Shanghai, our only direct
PRC subsidiary, is, however, subject to PRC restrictions on
distributions to equity holders. We currently intend for ACM
Shanghai to retain all available funds any future earnings for use
in the operation of its business and do not anticipate its paying
any cash dividends. We have not entered into, and do not expect to
enter into, investments for trading or speculative purposes. Our
accounts receivable balance fluctuates from period to period, which
affects our cash flow from operating activities. Fluctuations vary
depending on cash collections, client mix, and the timing of
shipment and acceptance of our tools.
Uses of Funds
Cash Flow from
Operating Activities. Our operations used cash flow of $4.6
million in the first six months of 2019. Our cash flow from
operating activities is influenced by (a) the amount of cash we
invest in personnel and technology development to support
anticipated future growth in our business, (b) the magnitude of our
product sales and associated gross profits, and (c) the amount and
timing of payments by customers.
Capital
Expenditures. We
estimate that our capital expenditures in 2019 will total
approximately $2.4 million. We incurred $505,000 of capital
expenditures during the six months ended June 30, 2019 and had no
unpaid capital commitment as of June 30, 2019. ACM Shanghai is
currently evaluating the desirability of entering into an agreement
to purchase land in the Shanghai PRC region that could serve as a
site for a future production facility and research and development
center, and that would require additional capital expenditures for
ACM Shanghai in 2019 or 2020.
Contractual
Obligations and Requirements. Our contractual obligations
and other commercial commitments are summarized in the section
captioned “Item 7. Management’s Discussion and Analysis
of Financial Condition and Results of Operations—Liquidity
and Capital Resources—Contractual Obligations and
Requirements” in our Annual Report. Other than changes that
occurred in the ordinary course of business, we had no material
changes to our contractual obligations reported in our Annual
Report during the first six months of 2019. For additional
discussion, see note 16 to our condensed consolidated financial
statements included elsewhere in this report.
Effects of Inflation
Inflation and
changing prices have not had a material effect on our business, and
we do not expect that they will materially affect our business in
the foreseeable future. Any impact of inflation on cost of revenue
and operating expenses, especially employee compensation costs, may
not be readily recoverable in the price of our product
offerings.
Off-Balance Sheet Arrangements
As of
June 30, 2019, we did not have any significant off-balance sheet
arrangements, as defined in Item303(a)(4)(ii) of Regulation S-K of
the Securities and Exchange Commission or SEC.
33
Emerging Growth Company Status
We are
an “emerging growth company” as defined in the
Jumpstart Our Business Startups Act, or JOBS Act, and may take
advantage of provisions that reduce our reporting and other
obligations from those otherwise generally applicable to public
companies. We may take advantage of these provisions until the
earliest of December 31, 2022 or such time that we have annual
revenue greater than $1.0 billion, the market value of our capital
stock held by non-affiliates exceeds $700 million or we have issued
more than $1.0 billion of non-convertible debt in a three-year
period. We have chosen to take advantage of some of these
provisions, and as a result we may not provide stockholders with
all of the information that is provided by other public companies.
We have, however, irrevocably elected not to avail ourselves, as
would have been permitted by Section 107 of the JOBS Act, of the
extended transition period provided in Section 7(a)(2)(B) of the
Securities Act of 1933 for complying with new or revised accounting
standards, and we therefore will be subject to the same new or
revised accounting standards as public companies that are not
emerging growth companies
Item 3. Quantitative and Qualitative
Disclosures about Market Risks
Market
risk represents the risk of loss that may impact our financial
position due to adverse changes in financial market prices and
rates. Our market risk exposure is primarily the result of
fluctuations in foreign exchange rates and interest rates. We do
not hold or issue financial instruments for trading
purposes.
Foreign Exchange Risk
Although our
financial statements and product pricing are denominated in U.S.
dollars, a sizable portion of our costs are denominated in other
currencies, primarily the RMB. The RMB is not freely convertible
into foreign currencies for capital account transactions. The value
of the RMB against the U.S. dollar and other currencies is affected
by changes in the PRC’s political and economic conditions and
by the PRC’s foreign exchange policies, among other things.
In July 2005, the PRC government changed its decades-old policy of
pegging the value of the RMB to the U.S. dollar, and the RMB
appreciated more than 20% against the U.S. dollar over the
following three years. Between July 2008 and September 2010, this
appreciation subsided and the exchange rate between the RMB and the
U.S. dollar remained within a narrow band. Since September 2010,
the RMB has fluctuated against the U.S. dollar, at times
significantly and unpredictably. It is difficult to predict how
market forces or PRC or U.S. government policy may impact the
exchange rate between the RMB and the U.S. dollar in the future. To
date, we have not entered into any hedging transactions in an
effort to reduce our exposure to foreign currency exchange
risk.
Interest Rate Risk
At June
30, 2019, we had unrestricted cash and cash equivalents totaling
$27.6 million. This amount was held for working capital purposes
and were held primarily in checking accounts of various banks. We
believe we do not have any material exposure to changes in our cash
balance as a result of changes in interest rates. Declines in
interest rates, however, would reduce future interest
income.
Item 4. Controls and
Procedures
Disclosure Controls and Procedures
Our
management, with the participation of our chief executive officer
and interim chief financial officer, evaluated the effectiveness of
our disclosure controls and procedures as of June 30, 2019. The
term “disclosure controls and procedures,” as defined
in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act
of 1934, means controls and other procedures of a company that are
designed to ensure that information required to be disclosed by a
company in the reports that it files or submits under the
Securities Exchange Act of 1934 is recorded, processed, summarized
and reported, within the time periods specified in the SEC’s
rules and forms. Disclosure controls and procedures include
controls and procedures designed to ensure that information
required to be disclosed by a company in the reports that it files
or submits under the Securities Exchange Act of 1934 is accumulated
and communicated to the company’s management, including its
principal executive and principal financial officers, as
appropriate to allow timely decisions regarding required
disclosure. Management recognizes that any controls and procedures,
no matter how well designed and operated, can provide only
reasonable assurance of achieving their objectives and management
necessarily applies its judgment in evaluating the cost-benefit
relationship of possible controls and procedures. Based on the
evaluation of our disclosure controls and procedures as of June 30,
2019, our chief executive officer and interim chief financial
officer concluded that, as of such date, our disclosure controls
and procedures over financial reporting were
effective.
Changes in Internal Control over Financial Reporting
During
the three months ended June 30, 2019, no changes were identified to
our internal control over financial reporting that materially
affected, or were reasonably likely to materially affect, our
internal control over financial reporting.
34
PART II. OTHER INFORMATION
Item 1A. Risk Factors
Investing in Class A common stock involves a high degree of risk.
You should consider and read carefully all of the information
contained in this report, including the consolidated financial
statements and related notes set forth in “Item 1. Financial
Statements” of Part I above, before making an investment
decision. You should also review carefully the risk factors set
forth in “Item 1A. Risk Factors” of Part I of our
Annual Report. Other than as set forth below, there have been no
material changes to those risk factors since the filing of our
Annual Report with the SEC on March 14, 2019. The occurrence of any
of the risks described in our Annual Report, or additional risks
and uncertainties not presently known to us or that we currently
believe to be immaterial, could materially and adversely affect our
business, financial condition, results of operations or cash flows.
In any such case, the trading price of Class A common stock could
decline, and you may lose all or part of your
investment.
If we are unable to implement our strategy to expand our PRC
operations by completing the Listing and the STAR IPO, our ability
to strengthen our market position and operations in the PRC,
including our ability to increase our revenues and augment our
product line, could be materially impaired.
We may
not be able to complete the Listing and the STAR IPO for a number
of reasons, many of which are outside our control. ACM Shanghai
must succeed in obtaining PRC governmental approvals required to
permit the Listing and the STAR IPO, and one or more of those
approvals may be denied, or significantly delayed, by the PRC
regulators for reasons outside our control or unknown to us.
Similarly, the Listing application may be denied or delayed by the
Shanghai Stock Exchange in its discretion.
If we
are unable to complete the Listing and the STAR IPO, we may not
otherwise be able to realize the advantages to our PRC operations
contemplated by our business strategy, including improving our
ability to market our products, building our brand in the PRC
markets, assisting our sales efforts to new customers and
encouraging additional purchases of our tools by existing
customers. Because it may be more than three years before we know
whether the Listing and the STAR IPO will be completed, we may, in
the interim, forego or postpone other alternative actions to
strengthen our market position and operations in the
PRC.
PRC
companies are critical to the global semiconductor industry, and
our current business is substantially concentrated in the PRC
market. Our inability to build, or any delay in growing, our
PRC-based operations over the next three years would materially and
adversely limit our operations and operating results, including our
revenue growth. In addition, during that time, the process
underlying the Listing and the STAR IPO could result in significant
diversion of management time as well as substantial out-of-pocket
costs, which could further impair our ability to expand our
business.
Even if we complete the Listing and the STAR IPO, we may not
achieve the results contemplated by our business strategy and our
strategy for growth in the PRC may not result in increases in the
price of the Class A common stock.
We
cannot assure you that, even if the Listing and the STAR IPO are
completed, we will realize any or all of our anticipated benefits
of the Listing and the STAR IPO. Our completion of the Listing and
the STAR IPO may not have the anticipated effects of including the
strengthening of our market position and operations in the PRC. If
the Listing and the STAR IPO are completed, ACM Shanghai will have
broad discretion in the use of the proceeds from the initial sales
of shares to investors and the proceeds from the STAR IPO, and it
may not spend or invest those proceeds in a manner that results in
our operating success or with which ACM Research stockholders
agree. Our failure to successfully leverage the completion of the
Listing and the STAR IPO to expand our PRC business could result in
a decrease in the price of the Class A common stock, and we cannot
assure you that the success of ACM Shanghai will have a an
attendant positive effect on the price of the Class A common
stock.
Completion of the
Listing and the STAR IPO may take three years or longer. In order
to help ensure that proceeds from the current placements of shares
with PRC investors can be repaid if necessary under the terms of
the applicable agreements, ACM Shanghai will reserve those proceeds
in segregated accounts and therefore those proceeds will not be
available to fund our operations in the PRC. In the interim, ACM
Shanghai may require additional funding from ACM Research in order
to proceed to augment its PRC operations, and we cannot give any
assurance that such capital will be available from ACM Research at
all in terms acceptable to us. Any such inability to obtain funds
may impair the ability of ACM Shanghai to grow its operations,
which could have a material adverse effect on our consolidated
operating results and on the price of the Class A common
stock.
35
ACM Shanghai’s status as a publicly traded company that is
controlled, but less than wholly owned, by ACM Research could have
an adverse effect on us.
As the
result of actions being taken in connection with the Listing and
the STAR IPO, ACM Shanghai will no longer be a wholly owned
subsidiary of ACM Research, and the interests of ACM Shanghai may
diverge from the interests of ACM Research and its other
subsidiaries in the future. We may face conflicts of interest in
managing, financing, engaging in transactions with ACM Shanghai, or
allocating business opportunities between our subsidiaries,
including future arrangements for operating subsidiaries other than
ACM Shanghai to license and use our intellectual property.
Substantially all of our intellectual property has been developed
in the PRC and is owned by ACM Shanghai. As we expand our global
operations through operating subsidiaries outside of the PRC, those
operating subsidiaries may need to license intellectual property
from ACM Shanghai in order to operate, and there can be no
assurance that conflicts of interest will not preclude those
operating subsidiaries from licensing the required intellectual
property from ACM Shanghai on reasonable terms or at
all.
ACM
Research will retain majority ownership of ACM Shanghai after the
STAR IPO, but ACM Shanghai will be managed by a separate board of
directors and officers and those directors and officers will owe
fiduciary duties to the various stakeholders of ACM Shanghai,
including ACM Research. In the operation of ACM Shanghai’s
business, there may be situations that arise whereby the directors
and officers of ACM Shanghai, in the exercise of their fiduciary
duties, take actions that may be contrary to the best interests of
ACM Research.
In the
future, ACM Shanghai may issue options, restricted shares and other
forms of share-based compensation to its directors, officers and
employees, which could dilute ACM Research’s ownership in ACM
Shanghai. In addition, ACM Shanghai may engage in capital raising
activities in the future that could further dilute ACM
Research’s ownership interest.
We may not be able to protect our intellectual property rights
throughout the world, including the PRC, which could materially,
negatively affect our business.
Filing,
prosecuting and defending patents on our products or proprietary
technologies in all countries throughout the world would be
prohibitively expensive, and our intellectual property rights in
some countries outside the United States, including the PRC, can be
less extensive than those in the United States. In addition, the
laws of some foreign countries do not protect intellectual property
rights to the same extent as federal and state laws in the United
States. Consequently, competitors may use our technologies in
jurisdictions where we have not obtained patent protection to
develop their own products and may export otherwise infringing
products to territories where we have patent protection but
enforcement is not as strong as that in the United States. These
products may compete with our products, and our patents or other
intellectual property rights may not be effective or sufficient to
prevent them from competing.
Substantially all
of our intellectual property has been developed in the PRC and is
owned by ACM Shanghai. Implementation and enforcement of
intellectual property-related laws in China has historically been
lacking due primarily to ambiguities in PRC intellectual property
law. Accordingly, protection of intellectual property and
proprietary rights in the PRC may not be as effective as in the
United States or other countries. As a result, third parties could
illegally use the technologies and proprietary processes that we
have developed and compete with us, which could negatively affect
any competitive advantage we enjoy, dilute our brand and harm our
operating results. Litigation may be necessary to enforce our
intellectual property rights, and given the relative
unpredictability of China’s legal system and potential
difficulties enforcing a court judgment in China, there is no
guarantee litigation would result in an outcome favorable to
us.
Many
companies have encountered significant problems in protecting and
defending intellectual property rights in foreign jurisdictions.
The legal systems of certain countries, particularly certain
developing countries, do not favor the enforcement of patents and
other intellectual property protection, which could make it
difficult for us to stop the infringement of our patents or
marketing of competing products in violation of our proprietary
rights generally. Proceedings to enforce our patent rights in
foreign jurisdictions could result in substantial costs and divert
our efforts and attention from other aspects of our business, could
put our patents at risk of being invalidated or interpreted
narrowly and our patent applications at risk of not issuing, and
could provoke third parties to assert claims against us. We may not
prevail in any lawsuits that we initiate, and the damages or other
remedies awarded, if any, may not be commercially meaningful.
Accordingly, our efforts to enforce our intellectual property
rights around the world may be inadequate to obtain a significant
commercial advantage from the intellectual property that we develop
or license and may adversely affect our business.
36
Proceeds received by ACM Shanghai in connection with the Listing
and the STAR IPO may not be available to ACM Research, which could
impair our efforts to expand outside of the PRC.
Proceeds received
by ACM Shanghai from the current placements of shares with PRC
investors and from the STAR IPO will be used to grow and support
our PRC operations. Those proceeds generally will not be available
for distribution to ACM Research. Under existing PRC laws and
regulations, it may be difficult, if not impossible, for ACM
Research to be able to receive dividends comprised of funds
generated by ACM Shanghai and, even if such dividends can be paid
from the PRC to the United States, after the completion of the
Listing and the STAR IPO, any such dividends can be paid to ACM
Research only if other holders of ACM Shanghai shares receive their
pro rata dividends.
ACM
Research will be responsible for managing our global expansion,
which will be critical to our long-term business success. Because
funds raised or generated by ACM Shanghai are unlikely to be
readily distributable to ACM Research, it is likely that ACM
Research will require additional capital in the future in order to
fund global operations. We cannot give any assurance that such
capital will be available at all in terms acceptable to
us.
No company with stock publicly traded in the United States has
effected a STAR Market listing of stock of a PRC-based subsidiary,
and it is therefore difficult to predict the effect of the proposed
Listing and STAR IPO on the Class A common stock.
The
China Securities Regulatory Commission initially launched the STAR
Market in June 2019 and trading on the Market began in July 2019.
We believe we are the first publicly traded U.S. company to propose
an initial public offering of shares of a PRC subsidiary on the
STAR Market. As a result, no assurance can be given regarding the
effect of the Listing and the STAR IPO on the market price of the
Class A common stock. The market price of Class A common stock may
be volatile or may decline, for reasons other than the risk and
uncertainties described above, as the result of investor negativity
or uncertainty with respect to the impact of the proposed Listing
and STAR IPO.
ACM
Research stockholders were not entitled to purchase ACM Shanghai
shares in the pre-Listing placement, and they may have limited
opportunities to purchase ACM Shanghai shares even if the Listing
and the STAR IPO are completed. Investors may elect to invest in
our business and operations by purchasing ACM Shanghai shares in
the STAR IPO or on the STAR Market rather than purchasing ACM
Research Class A common stock, and that reduction in demand could
lead to a decrease in the market price for the Class A common
stock.
Techniques employed by manipulative short sellers in Chinese small
cap stocks could be used to drive down the market price of our
common stock.
Short
selling is the practice of selling securities that the seller does
not own but rather has, supposedly, borrowed from a third party
with the intention of buying identical securities back at a later
date to return to the lender. The short seller hopes to profit from
a decline in the value of the securities between the sale of the
borrowed securities and the purchase of the replacement shares, as
the short seller expects to pay less in that purchase than it
received in the sale. As it is in the short seller’s best
interests for the price of the stock to decline, many short
sellers, referred to as “disclosed shorts,” publish, or
arrange for the publication of, negative opinions regarding an
issuer and its business prospects in order to create negative
market momentum and generate profits for themselves after selling a
stock short. While traditionally these disclosed shorts were
limited in their ability to access mainstream business media or to
otherwise create negative market rumors, the rise of the Internet
and technological advancements regarding document creation,
videotaping and publication by weblog, or “blogging,”
have allowed many disclosed shorts to publicly attack an
issuer’s credibility, strategy and veracity by means of
so-called research reports that mimic the type of investment
analysis performed by large Wall Street firm and independent
research analysts. These short attacks have, in the past, led to
selling of shares in the market, on occasion in large scale and
broad base. Issuers with business operations based in the PRC and
who have limited trading volumes and are susceptible to higher
volatility levels than large-cap stocks, can be particularly
vulnerable to such short attacks.
These
short seller publications are not regulated by any governmental,
self-regulatory organization or other official authority in the
United States and are not subject to the certification requirements
imposed by the Securities and Exchange Commission in Regulation AC
(Regulation Analyst Certification); accordingly, the opinions they
express may be based on factual distortions and fabrications. In
light of the limited risks involved in publishing such information
and the enormous profits that can be made from running successful
short attacks, it is likely that disclosed shorts will continue to
issue such reports.
While
we intend to strongly defend our public filings against any short
seller attacks, we may be constrained, either by principles of
freedom of speech, applicable state laws known as Anti-SLAPP
(Strategic Lawsuits Against Public Participation) statutes or
issues of commercial confidentiality, in the manner in which we can
proceed against the short seller. You should be aware that in light
of the relative freedom to operate that such persons enjoy –
oftentimes blogging from outside the U.S. with little or no assets
or identity requirements – should we be targeted for such an
attack, our stock will likely suffer from a temporary, or possibly
long term, decline in market price should the rumors created not be
dismissed by market participants.
37
Item 2. Unregistered Sales of Equity
Securities and Use of Proceeds
Recent Sales of Unregistered Equity Securities
In June
2019 we issued and sold to an employee an aggregate of 2,001
unregistered shares of Class A common stock upon the exercise of
stock options at a per share exercise price of $1.50. These
transactions did not involve any underwriters, any underwriting
discounts or commissions, or any public offering. We believe the
offers, sales and issuances of these shares were exempt from
registration under the Securities Act of 1933 by virtue of Section
4(a)(2) thereof (or Regulation D promulgated thereunder) because
the issuance of securities to the recipients did not involve a
public offering or in reliance on Rule 701 under said Act because
the transactions were pursuant to a contract relating to
compensation as provided under such rule. The recipients of the
shares represented their intentions to acquire the securities for
investment only and not with a view to or for sale in connection
with any distribution thereof, and appropriate legends were placed
upon the shares issued in these transactions. The recipients had
adequate access, through a relationship with us, to information
about us. The sales of these shares were made without any general
solicitation or advertising.
Use of Initial Public Offering Proceeds
The net
proceeds of our initial public offering of Class A common stock in
November 2017, after deducting underwriting discounts and
commissions and offering expenses, were $17.3 million. There has
been no material change in the planned use of proceeds from that
described in the final prospectus filed with the SEC pursuant to
Rule 424(b)(4) under the Securities Act of 1933 on November 3,
2017. To date we have applied $10.8 million of the net proceeds to
purchase inventory and an additional $2.1 million in the ordinary
course of business operations.
Item 6.Exhibits
The
following exhibits are being filed as part of this
report:
Exhibit
Number
|
|
Description
|
||
|
Form of
Capital Increase Agreement between ACM Research, Inc. and certain
investors
|
|||
|
Schedule
identifying agreements substantially identical to the form of
Capital Increase Agreement filed as Exhibit 10.01 hereto
|
|||
|
Form of
Agreement between ACM Research, Inc. and certain Investors
|
|||
|
Schedule
identifying agreements substantially identical to the form of
Agreement filed as Exhibit 10.02 hereto
|
|||
|
Certification of
Principal Executive Officer Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
|||
|
Certification of
Principal Financial Officer Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
|||
|
Certification of
Principal Executive Officer and Principal Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|||
101.INS
|
|
XBRL
Instance Document
|
||
101.SCH
|
|
XBRL
Taxonomy Extension Schema Document
|
||
101.CAL
|
|
XBRL
Taxonomy Extension Calculation Linkbase Document
|
||
101.DEF
|
|
XBRL
Taxonomy Extension Definition Linkbase Document
|
||
101.LAB
|
|
XBRL
Taxonomy Extension Label Linkbase Document
|
||
101.PRE
|
|
XBRL
Taxonomy Extension Presentation Linkbase Document
|
38
SIGNATURE
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
|
ACM
RESEARCH, INC.
|
|
|
|
|
Date:
August 9,
2019
|
By:
|
/s/
Lisa Feng
|
|
|
Lisa
Feng
|
|
|
Interim
Chief Financial Officer, Chief Accounting Officer and Treasurer
(Principal Financial Officer)
|
39